KR20120056520A - Method for developing gene specific molecular markers - Google Patents

Method for developing gene specific molecular markers Download PDF

Info

Publication number
KR20120056520A
KR20120056520A KR1020100118096A KR20100118096A KR20120056520A KR 20120056520 A KR20120056520 A KR 20120056520A KR 1020100118096 A KR1020100118096 A KR 1020100118096A KR 20100118096 A KR20100118096 A KR 20100118096A KR 20120056520 A KR20120056520 A KR 20120056520A
Authority
KR
South Korea
Prior art keywords
seq
molecular marker
gene
bean
amplifying
Prior art date
Application number
KR1020100118096A
Other languages
Korean (ko)
Other versions
KR101263785B1 (en
Inventor
정우석
김성기
김진원
최병열
박나영
김진만
Original Assignee
건국대학교 산학협력단
경기도
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 건국대학교 산학협력단, 경기도 filed Critical 건국대학교 산학협력단
Priority to KR1020100118096A priority Critical patent/KR101263785B1/en
Publication of KR20120056520A publication Critical patent/KR20120056520A/en
Application granted granted Critical
Publication of KR101263785B1 publication Critical patent/KR101263785B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6865Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE: A method for developing a frogeye leaf spot resistant gene-specific molecular marker is provided to distinguish different species at a genomic level. CONSTITUTION: A method for developing a molecular marker comprises: a step of isolating genomic DNA with different reactivities to frogeye leaf spot; a step of searching for a gene which is similar to a sequence of the MYB transcription regulatory gene of Glycine m from the DNA base sequence database of Medicago truncatula; a step of searching for a promoter site from the database; a step of designing a PCR primer for amplifying a specific site of the promoter; a step of amplifying the promoter site using a primer and genomic DNA; and a step of confirming a pattern.

Description

콩 점무늬병 저항성 유전자 특이적 분자마커의 개발 방법{METHOD FOR DEVELOPING GENE SPECIFIC MOLECULAR MARKERS}METHOD FOR DEVELOPING GENE SPECIFIC MOLECULAR MARKERS}

본 발명은 콩 점무늬병 저항성 유전자 특이적 분자마커의 개발 방법에 관한 것으로서, 보다 구체적으로는 Medicago truncatula의 게놈 유전자에서 내재해 관련 콩 MYB 전사조절유전자들의 염기서열과 유사한 유전자를 발굴하고, 이들 유전자의 프로모터 부위에서 다형성을 관찰, 분석하여 콩의 개화 특성을 검정하고, 이를 특징으로 하는 콩 품종을 판별할 수 있는 유전자 특이적 분자마커를 개발하는 방법에 관한 것이다.The present invention relates to a method for developing a soybean spot disease resistant gene-specific molecular marker, more specifically Medicago The genome genes of truncatula inherent in the genome of the relevant soybean MYB transcriptional regulators, genes similar to those found, and polymorphisms observed in the promoter region of these genes by examining and analyzing the flowering characteristics of the soybean varieties characterized by The present invention relates to a method for developing a gene-specific molecular marker that can be discriminated.

콩 점무늬병은 Cercospora sojina Hara에 의한 병으로서, 최근 경기북부지역을 중심으로 전국적으로 그 피해가 확산되고 있고 있으며, 콩의 잎과 줄기는 물론 꼬투리나 종자에 발생하여 수확량을 감소시키는 중요한 병이다. 이 병원균에 대한 콩 품종별 반응은 다양하나, 국내에서는 최근에서야 점무늬병을 일으키는 균의 품종 분포조사가 이루어졌으며, 품종별 병원성 검정 및 균 판별 품종에 대한 보고가 나왔다(김 등 2009. 지역특화기술개발보고서 발간등록번호 11-1390000-002219-01).Bean spots Cercospora It is a disease caused by sojina Hara, and its damage is spreading all over the country in the northern part of Gyeonggi-do recently. It is an important disease that occurs in pods and seeds as well as leaves and stems of beans. Varieties of soybean varieties to this pathogen vary, but only recently in Korea, the distribution of strains causing spot pattern disease has been investigated, and the pathogenicity test and the discrimination of varieties have been reported (Kim et al. 2009. Regional Specialized Technology Development). Report Publication No. 11-1390000-002219-01).

점무늬병 저항성 품종을 육성하기 위한 선발은 콩 생육기 V3 ~ V5 사이의 발육단계에서 병원균을 접종한 후 14일, 21일 경과 시점에서 병반의 크기 2 mm를 기준으로 감수성과 저항성을 구분한다. 이러한 실험 과정으로 인하여 대규모 실외 및 실내 실험을 수행할 때 어려움이 많이 발생하며, Cercospora sojina Hara 균의 대량 배양, 선발 대상계통의 생육기 조절 등 여러 가지 기술적 어려움이 동반된다. 이에 따라 점무늬병 저항성과 관련된 분자마커의 개발은 점무늬병에 대해 저항성을 보이는 계통의 선발에 필요한 시간과 비용을 절감할 수 있는 효과적인 대안으로 제시되었다. Selection for the development of resistant varieties of mucus disease is distinguished from susceptibility and resistance on the basis of 2 mm of lesion size at 14 days and 21 days after inoculation of pathogens in the growth stage between soybean growing period V3 ~ V5. Due to this experiment process, a lot of difficulties arise when conducting large-scale outdoor and indoor experiments. Cercospora Many technical difficulties are accompanied, such as mass cultivation of sojina Hara, and control of the growing season of the selected system. Therefore, the development of molecular markers related to spot disease resistance has been suggested as an effective alternative to reduce the time and cost required for the selection of strains resistant to spot disease.

현재, 유전자 특이적 분자마커는 주로 유전자의 단백질 합성에 관여하는 암호화 부위(coding region)로부터 다형성을 발굴하고 있으나, 이 방법으로는 PCR 프라이머(PCR primer)를 제작하기에 충분한 다형성을 찾기가 매우 어렵다는 문제점이 있으며, 기존에 보고된 대부분의 암호화 부위(coding region)의 다형성이 관찰되어 마커로 시도되었던 것들은 몇 개의 뉴클레오티드만이 다른 단일염기다형성(single nucleotide polymorphism, SNP)이었다.Currently, gene-specific molecular markers are discovering polymorphisms from coding regions that are primarily involved in protein synthesis of genes, but it is very difficult to find enough polymorphisms to construct PCR primers. There was a problem, and most of the reported polymorphisms of coding regions were observed and attempted as markers were single nucleotide polymorphisms (SNPs) with only a few nucleotides.

본 발명에서는 식물의 점무늬병 저항성 관련 전사조절 단백질인 MYB 전사조절요소(transcription factor) 유전자들의 프로모터를 이용하여 콩 점무늬병 관련 유전자 특이적 분자마커를 개발하였다. 각각의 MYB 전사조절유전자의 프로모터 부위를 증폭하였을 때 품종 간 다형성을 보이는 프라이머를 이용하여, 콩 점무늬병에 대한 저항성 정도가 다르게 보이는 각 품종의 표현형과 각각의 MYB 전사조절유전자의 유전적 특성을 비교하여 콩 점무늬병 저항성 관련 MYB 유전자 특이적 분자마커를 개발하게 되었다. In the present invention, soybean spot disease-related gene-specific molecular markers have been developed using promoters of MYB transcription factor genes, which are transcriptional regulatory proteins related to plant disease. Using primers showing polymorphism between varieties when amplifying the promoter region of each of the MYB transcription control genes, and in each variety phenotype the resistance degree for the bean jeommunuibyeong looks different compared with the dielectric properties of each of the MYB transcription control genes We have developed a MYB gene-specific molecular marker for soybean spot disease resistance.

본 발명은 상기의 문제점을 해결하고 상기의 필요성에 의하여 안출된 것으로서, 본 발명이 이루고자 하는 기술적 과제는 식물의 내재해 관련 전사조절 단백질인 MYB 전사조절 요소(transcription factor) 유전자 프로모터 부위의 유전적 다형성을 발굴하여, 이러한 다형성을 나타내는 프라이머를 콩 점무늬병과 관련된 분자마커로 개발하는 방법을 제공하는 데 있다.The present invention has been made in view of the above problems and the need for the above, the technical problem to be achieved by the present invention is a genetic polymorphism of the gene promoter region of MYB transcription regulation factor gene that is a transcriptional regulatory protein associated with plant injuries By exploring this, it is to provide a method for developing a primer that represents this polymorphism as a molecular marker associated with soybean spot disease.

상기의 목적을 달성하기 위하여, 본 발명은 콩 점무늬병 저항성 유전자 특이적 분자마커의 개발 방법을 제공한다.In order to achieve the above object, the present invention provides a method for the development of soybean spot disease resistant gene specific molecular markers.

본 발명에 있어서, 상기 분자마커의 개발 방법은 (1) 콩 점무늬병에 대한 반응성이 서로 다른 콩의 품종별 게놈 DNA(genomic DNA)를 추출하는 단계; (2) Medicago truncatula의 DNA 염기서열 데이터베이스로부터 콩(Glycine max)의 MYB 전자조절유전자의 염기서열과 유사한 유전자를 찾아내는 단계; (3) 상기 Medicago truncatula의 DNA 염기서열 데이터베이스로부터 상기 (2) 단계에서 찾아낸 유전자의 프로모터 부위를 발굴하는 단계; (4) 상기 프로모터의 특정 부위를 증폭할 수 있는 PCR 프라이머(primer)를 제작하는 단계; (5) 상기 (1) 단계의 게놈 DNA(genomic DNA)를 주형으로 하고, (4) 단계의 프라이머를 이용하여 특정 유전자의 프로모터 부위를 증폭하는 단계; 및 (6) 상기 증폭된 특정 유전자의 프로모터 부위에서 다형성을 관찰, 분석하여 계통 간 분자마커로 사용될 수 있는 패턴을 확인하는 단계를 포함하는 것을 특징으로 한다.In the present invention, the method of developing the molecular marker comprises the steps of: (1) extracting genomic DNA (genomic DNA) for each variety of soybeans with different reactivity to soybean spot pattern disease; (2) finding a gene similar to the nucleotide sequence of the MYB electron regulator gene of soybean ( Glycine max ) from the DNA sequence database of Medicago truncatula ; (3) discovering a promoter region of the gene found in step (2) from the DNA sequence database of the Medicago truncatula ; (4) preparing a PCR primer capable of amplifying a specific site of the promoter; (5) using the genomic DNA of step (1) as a template and amplifying a promoter region of a specific gene using the primer of step (4); And (6) observing and analyzing the polymorphism at the promoter region of the amplified specific gene to identify a pattern that can be used as a molecular marker between strains.

본 발명은 콩 점무늬병 관련된 새로운 분자마커를 개발하는 방법을 제공하며, 본 발명에 따르면 PCR을 통해 증폭된 밴드 패턴으로 콩 품종별 다형성의 차이점을 발굴하고 이를 분자마커로 이용하는 것이 가능하다. 본 발명에 의하여 발굴된 분자마커는 콩 점무늬병에 대한 반응 정도가 다른 품종을 유전체 수준에서 구별하는 것이 가능하며, 콩 점무늬병 특이적 분자마커로 활용 가능하다.The present invention provides a method for developing a new molecular marker associated with soybean spot disease, according to the present invention it is possible to discover the difference in polymorphism for each of the soybean varieties in a band pattern amplified by PCR and use it as a molecular marker. The molecular markers discovered by the present invention can distinguish varieties having different degrees of response to soybean spot disease at the genome level, and can be used as soybean spot disease specific molecular markers.

도 1은 콩(Glycine max)의 MYB 전사조절유전자(서열번호 1)를 query로 이용하여 BLAST를 통해 발굴한 Medicago truncatula 의 유사 MYB 전사조절유전자이다.
도 2는 콩(Glycine max)의 MYB 전사조절유전자(서열번호 2)를 query로 이용하여 BLAST를 통해 발굴한 Medicago truncatula 의 유사 MYB 전사조절유전자이다.
도 3은 콩(Glycine max)의 MYB 전사조절유전자(서열번호 3)를 query로 이용하여 BLAST를 통해 발굴한 Medicago truncatula 의 유사 MYB 전사조절유전자이다.
도 4는 콩(Glycine max)의 MYB 전사조절유전자(서열번호 4)를 query로 이용하여 BLAST를 통해 발굴한 Medicago truncatula 의 유사 MYB 전사조절유전자이다.
도 5는 콩(Glycine max)의 MYB 전사조절유전자(서열번호 5)를 query로 이용하여 BLAST를 통해 발굴한 Medicago truncatula 의 유사 MYB 전사조절유전자이다.
도 6은 콩(Glycine max)의 MYB 전사조절유전자(서열번호 6)를 query로 이용하여 BLAST를 통해 발굴한 Medicago truncatula 의 유사 MYB 전사조절유전자이다.
도 7은 Medicago truncatula 의 유사 MYB 전사조절유전자의 프로모터를 증폭할 수 있도록 제작된 프라이머(서열번호 19 ~ 30)와 콩 점무늬병에 대해 다른 반응을 보이는 콩 품종의 게놈 DNA(genomic DNA)를 주형으로 하여 증폭된 DNA 밴드 패턴을 나타낸 사진이다.
도 8은 상기 도 7의 밴드 패턴을 NT sys 분석하여 얻은 콩 품종간의 근연관계를 나타낸 계통수(phylogenetic tree)이다.
1 is a bean ( Glycine max ) Medicago discovered through BLAST using the MYB transcriptional regulator gene (SEQ ID NO: 1) as a query It is a similar MYB transcriptional regulator of truncatula .
2 is a bean ( Glycine max ) Medicago discovered through BLAST using MYB transcriptional regulatory gene (SEQ ID NO: 2) as a query It is a similar MYB transcriptional regulator of truncatula .
3 is a bean ( Glycine max ) Medicago discovered through BLAST using MYB transcriptional regulator gene (SEQ ID NO: 3) as a query It is a similar MYB transcriptional regulator of truncatula .
4 is a bean ( Glycine max ) Medicago discovered through BLAST using MYB transcriptional regulator gene (SEQ ID NO: 4) as a query It is a similar MYB transcriptional regulator of truncatula .
5 is a bean ( Glycine max ) Medicago discovered through BLAST using MYB transcriptional regulator gene (SEQ ID NO: 5) as a query It is a similar MYB transcriptional regulator of truncatula .
6 is a bean ( Glycine max ) Medicago discovered through BLAST using MYB transcriptional regulatory gene (SEQ ID NO: 6) as a query It is a similar MYB transcriptional regulator of truncatula .
7 is Medicago DNA bands amplified using primers (SEQ ID NOs: 19-30) designed to amplify the promoters of similar MYB transcriptional regulators of truncatula and genomic DNA of soybean varieties that respond differently to soybean spots Photo shows the pattern.
FIG. 8 is a phylogenetic tree showing the relationship between soybean varieties obtained by NT sys analysis of the band pattern of FIG. 7.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명은 콩 점무늬병 저항성 유전자 특이적 분자마커의 개발 방법을 제공한다.The present invention provides a method for developing a soybean spot disease resistant gene specific molecular marker.

본 발명에 있어서, 상기 분자마커의 개발 방법은 (1) 콩 점무늬병에 대한 반응성이 서로 다른 콩의 품종별 게놈 DNA(genomic DNA)를 추출하는 단계; (2) Medicago truncatula의 DNA 염기서열 데이터베이스로부터 콩(Glycine max)의 MYB 전사조절유전자의 염기서열과 유사한 유전자를 찾아내는 단계; (3) 상기 Medicago truncatula의 DNA 염기서열 데이터베이스로부터 상기 (2) 단계에서 찾아낸 유전자의 프로모터 부위를 발굴하는 단계; (4) 상기 프로모터의 특정 부위를 증폭할 수 있는 PCR 프라이머(primer)를 제작하는 단계; (5) 상기 (1) 단계의 게놈 DNA(genomic DNA)를 주형으로 하고, (4) 단계의 프라이머를 이용하여 특정 유전자의 프로모터 부위를 증폭하는 단계; 및 (6) 상기 증폭된 특정 유전자의 프로모터 부위에서 다형성을 관찰, 분석하여 계통 간 분자마커로 사용될 수 있는 패턴을 확인하는 단계를 포함한다.In the present invention, the method of developing the molecular marker comprises the steps of: (1) extracting genomic DNA (genomic DNA) for each variety of soybeans with different reactivity to soybean spot pattern disease; (2) finding a gene similar to the nucleotide sequence of the MYB transcriptional regulator gene of soybean ( Glycine max ) from the DNA sequence database of Medicago truncatula ; (3) discovering a promoter region of the gene found in step (2) from the DNA sequence database of the Medicago truncatula ; (4) preparing a PCR primer capable of amplifying a specific site of the promoter; (5) using the genomic DNA of step (1) as a template and amplifying a promoter region of a specific gene using the primer of step (4); And (6) observing and analyzing polymorphism at the promoter region of the specific amplified gene to identify a pattern that can be used as a molecular marker between lines.

본 발명에 있어서, 상기 콩 품종은 보광콩, 장원콩, 금강콩, 청자콩3호, 안평콩, 대망콩, 다채콩 및 태광콩으로 이루어진 군에서 선택되는 1종 이상인 것을 특징으로 한다.In the present invention, the soybean varieties are characterized in that at least one selected from the group consisting of Bokwang beans, Jangwon beans, Geumgang beans, Cheongja bean No. 3, Anpyeong beans, Daeman beans, Dachae beans and Taekwang beans.

본 발명의 상기 (3) 단계는 상기 (2) 단계에서 찾아낸 유전자 염기서열의 5' 방향 상위 1.5 ~ 2 Kb 부위에서 프로모터를 발굴하며, 상기 (4) 단계는 특정 유전자의 프로모터가 포함되는 개시코돈으로부터 5' 방향으로 10 Kb 내부에서 복수의 프라이머를 제작하는 것을 특징으로 한다.Step (3) of the present invention discovers a promoter at the top 1.5 ~ 2 Kb region of the 5 'direction of the gene sequence found in step (2), step (4) is the start codon including the promoter of a specific gene It characterized in that a plurality of primers are produced in 10 Kb in the 5 'direction from.

본 발명에서 찾아 낸 내재해 관련 콩(Glycine max) MYB 전사조절유전자는 서열번호 1 내지 6으로 기재된 염기서열 중에서 선택된 1 이상인 것을 특징으로 하며, Medicago truncatula의 DNA 염기서열 데이터베이스로부터 찾아낸 상기 특정 유전자와 유사한 염기서열은 서열번호 7 내지 12로 기재된다.Soybean-related beans found in the present invention ( Glycine max ) MYB transcriptional regulator is characterized in that at least one selected from the nucleotide sequences set forth in SEQ ID NO: 1 to 6, Medicago Sequences similar to the specific genes found in the truncatula DNA sequencing database are set forth in SEQ ID NOs: 7-12.

본 발명에 있어서, 상기 서열번호 7 내지 12로 기재되는 콩(Glycine max) MYB 전사조절유전자 유사 염기서열로부터 발굴한 프로모터 부위는 서열번호 13 내지 18로 기재되는 것이며, 각각의 프로모터 부위를 증폭할 수 있는 프라이머는 서열번호 19 내지 30으로 기재되는 것이다.In the present invention, soybean ( Glycine) described in SEQ ID NOs: 7 to 12 max ) Promoter sites discovered from MYB transcriptional regulator-like sequences are shown in SEQ ID NOs: 13-18, and primers capable of amplifying each promoter site are described in SEQ ID NOs: 19-30 .

또한, 본 발명은 상기 분자마커의 개발 방법에 의하여 제작된 콩 점무늬병 관련 유전자 특이적 분자마커를 제공한다.
The present invention also provides a soybean spot disease related gene specific molecular markers produced by the method of developing the molecular marker.

이하, 실시예에 의하여 본 발명을 더욱 상세히 설명하고자 한다.Hereinafter, the present invention will be described in more detail with reference to Examples.

단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계의 통상의 지식을 가진 자에게 있어서 자명할 것이다.
However, the following examples are only for illustrating the present invention, it will be apparent to those skilled in the art that the scope of the present invention is not interpreted to be limited by these examples.

실시예Example 1. 콩 점무늬병 판별품종의  1. Soybean Spotted Disease Identification DNADNA 추출 extraction

콩 점무늬병에 대하여 균의 레이스(race)에 따라 저항성(R) 또는 감수성(S) 등 서로 다른 반응을 나타내는 콩의 판별품종은 김 등 (2009, 지역특화기술개발보고서 발간등록번호 11-1390000-002219-01)에 의하여 보고된 바 있다. 김 등에 의하면, 보광콩은 우리나라에서 발견되는 콩 점무늬병을 일으키는 균의 race의 형태(Cs-2, Cs-10, Cs-14, Cs-16, Cs-19, Cs-20)에 모두 저항성을 보이는 반면, 태광콩은 상기 race들에 모두 감수성을 보였다.The different varieties of soybeans that have different reactions such as resistance (R) or susceptibility (S) to soybean spot pattern disease are Kim et al. (2009, Regional Technology Development Report Publication No. 11-1390000-002219 -01). According to Kim et al., Bokwang soybeans are resistant to all types of races (Cs-2, Cs-10, Cs-14, Cs-16, Cs-19, and Cs-20) that cause soy spots in Korea. On the other hand, Taekwang showed sensitivity to all of the races.

Figure pat00001
Figure pat00001

본 발명에서는 우리나라에서 발병되는 콩 점무늬병원균의 race를 판별할 수 있는 품종으로 알려진 보광콩, 장원콩, 금강콩, 청자콩3호, 안평콩, 대망콩, 다채콩, 태광콩을 시료로 사용하였다. In the present invention, Bogwang beans, Jangwon beans, Geumgang beans, Cheongja beans No. 3, Anpyeong beans, Daemong beans, Dachae beans, Taegong beans, which are known as varieties capable of discriminating the race of soybean spot pathogens in Korea, were used as samples.

각 콩 품종의 잎 5 g을 막자사발에 넣고 액체 질소를 공급하면서 곱게 갈아 15 ㎖ 튜브에 넣어, DNA 추출 완충액(DNA extraction buffe; 5 M NaCl 100 ㎖, 1 M Tris-HCl(pH8.0) 100 ㎖, 0.25 M EDTA 200 ㎖, 20% SDS 62.5 ㎖, Sodium bisulfite 0.38 g/buffer 100 ㎖) 6 ㎖를 첨가한 뒤에 65℃ 항온 수조(water bath)에 20분 간 넣어 두었다. 여기에 동량의 클로로포름 아이소아밀알코올(chloroform isoamylalchohol, 24:1(v/v))액을 넣고 20분 정도 흔들어 준 뒤 4℃ 원심분리기에서 3,000 rpm으로 원심분리 하였다.5 g of leaves of each bean variety are placed in a mortar and finely ground in a 15 ml tube while supplying liquid nitrogen, DNA extraction buffe (100 ml of 5 M NaCl, 1 M Tris-HCl (pH 8.0) 100 ㎖, 200 ml of 0.25 M EDTA, 62.5 ml of 20% SDS, and 6 ml of 0.38 g / buffer 100 ml of Sodium bisulfite were added and placed in a 65 ° C. water bath for 20 minutes. An equal amount of chloroform isoamylalchohol (24: 1 (v / v)) was added thereto, shaken for about 20 minutes, and centrifuged at 3,000 rpm in a 4 ° C centrifuge.

그 다음 상징액을 취해, 새로운 튜브에 옮긴 후 2배의 에탄올 또는 2/3배의 아이소프로판올(isopropanol)을 첨가하여 DNA를 침전시켰다. 엉긴 DNA를 70% 에탄올에 세척하여 1.5 ㎖ 튜브로 옮긴 다음 공기 중에 건조시켰다. 다음으로, TE 완충액(TE buffer; 10 mM Tris-HCl, 1 mM EDTA, pH7.4) 300 ㎕에 건조된 DNA를 녹이고 50 ~ 60℃ 항온기에 넣어 DNase의 활성을 제거시키고 RNase(1 ㎎/㎖) 4 ㎕를 넣어 잘 흔들어 준 후 37℃에 1시간 정도 보관하여 RNA를 제거하여, DNA를 추출하였다.
The supernatant was then taken, transferred to a new tube, and DNA was precipitated by adding 2x ethanol or 2 / 3x isopropanol. The tangled DNA was washed in 70% ethanol, transferred to a 1.5 ml tube and dried in air. Next, the dried DNA was dissolved in 300 μl of TE buffer (TE buffer; 10 mM Tris-HCl, 1 mM EDTA, pH7.4), and placed in a thermostat at 50-60 ° C. to remove DNase activity and RNase (1 mg / ml). ) 4 µl of the solution was shaken well, stored at 37 ° C. for about 1 hour, RNA was removed, and DNA was extracted.

실시예 2. 콩(Example 2. Soybeans Glycine maxGlycine max )의 )of MYBMYB 전사조절유전자와 유사한 염기서열을 갖는  Having a nucleotide sequence similar to a transcriptional regulator Medicago truncatulaMedicago truncatula 의 유사 유전자 발굴Finding similar genes in

본 발명에서 사용한 내재해 관련 콩(Glycine max)의 MYB 전사조절유전자의 염기서열은 서열번호 1 내지 6으로 기재된다.Soybean-related beans ( Glycine) used in the present invention max ) the nucleotide sequence of MYB transcriptional regulator genes are set forth in SEQ ID NOs: 1-6.

상기 염기서열을 쿼리(query)로 하여 Medicago truncatula 서열 데이터베이스(sequencing database, GenBank, www.ncbi.nlm.nih.gov)에서 BLAST하여 찾아낸 결과는 도 1 내지 6에 정리하였으며, 콩(Glycine max)의 MYB 전사조절유전자와 e-20 이상 수준의 유사성을 갖는 Medicago truncatula의 염기서열은 서열번호 7 내지 12로 기재된다. 서열번호 7 내지 12로 기재되는 각각의 염기서열은 도 1 내지 6에 나타난 것과 같이 Medicago truncatula 서열 데이터베이스의 BAC sequencing library의 AC137831, AC137831, AC153001, AC166313, CT025844, AC122724에서 발굴된 것이다. 또한, 도 1 내지 6에 제시되었듯이 위 콩(Glycine max)의 MYB 전사조절유전자 중 서열번호 1, 2, 5는 1개의 염기서열이, 서열번호 3, 4, 6은 1개 이상의 염기서열이 e-20 이상 수준의 유사성을 갖는 것으로 나타났다. Medicago using the nucleotide sequence as a query BLAST results from the truncatula sequence database (sequencing database, GenBank, www.ncbi.nlm.nih.gov ) are summarized in Figures 1 to 6, the MYB transcriptional regulator of soybean ( Glycine max ) and the level of e-20 or more The base sequences of Medicago truncatula with similarities are set forth in SEQ ID NOs: 7-12. Each base sequence set forth in SEQ ID NOS: 7-12 is Medicago as shown in FIGS. It was discovered at AC137831, AC137831, AC153001, AC166313, CT025844 and AC122724 of the BAC sequencing library of the truncatula sequence database. In addition, gastric beans ( Glycine) as shown in Figures 1 to 6 max ) MYB transcriptional regulator genes of SEQ ID NO: 1, 2, 5 is one nucleotide sequence, SEQ ID NO: 3, 4, 6 was shown that one or more nucleotide sequences have a level of e-20 or more similarity.

실시예Example 3.  3. MedicagoMedicago truncatulatruncatula of MYBMYB 전사조절유전자 유사 염기서열로부터 프로모터 염기서열의 발굴 Identification of Promoter Sequences from Transcription Gene-like Sequences

상기 실시예 2에서 발굴한 유전자 염기서열의 유사성을 바탕으로 위와 같이 일치되는 염기서열의 5' 방향의 염기서열은 프로모터 역할을 하는 부위가 포함된 것으로 추정 가능하며, 이 프로모터 역할을 하는 부분의 염기서열을 추출하고자 C 언어로 프로그래밍 한 프로그램 get_seq2를 자체 개발하여 사용하였다. Based on the similarity of the gene base sequence found in Example 2 , the base sequence in the 5 'direction of the base sequence matched as above can be estimated to include a site serving as a promoter, and the base of the part serving as the promoter. In order to extract the sequence, the program get_seq2 programmed in C language was developed and used.

Medicago truncatula에서 발굴한 콩(Glycine max)의 MYB 전사조절유전자와 고도의 유의성을 갖는 상기 염기서열(서열번호 7 내지 12)을 이용하여 각각 일치하는 염기(base)가 시작되는 5' 말단으로부터 상부(5' 방향) 약 2 Kb 가량의 염기서열을 동일한 Medicago truncatula 게놈 서열 데이터베이스에서 추출하였다. 이러한 방법으로 발굴한 Medicago truncatulaMYB 유사 유전자 각각의 프로모터 부위를 포함하는 염기서열은 서열번호 13 내지 18로 기재된다.
Medicago beans excavated from truncatula (Glycine max ) using the base sequence (SEQ ID NOS: 7-12) having a high degree of significance with MYB transcriptional regulator gene of about 2 Kb from the 5 'end to the start of the corresponding base (5' direction) Sequence of the same Medicago Extracted from truncatula genomic sequence database. Medicago discovered in this way The base sequences comprising the promoter region of each MYB- like gene of truncatula are set forth in SEQ ID NOs: 13-18.

실시예Example 4. 콩 점무늬병 저항성 유전자 관련  4. Related to soybean spot disease resistance gene 분자마커Molecular Marker 개발 Development

4-1) 특정 프로모터 부위를 증폭할 수 있는 4-1) Amplify Specific Promoter Sites 프라이머primer 제작 making

상기 각각의 프로모터 부위를 포함하는 염기서열(서열번호 13 내지 18)의 특정부위를 증폭할 수 있는 각각의 프라이머를 제작하였으며, 서열번호 19 내지 30으로 나타내었다. 서열번호 19와 20으로 기재되는 프라이머는 서열번호 13의 염기서열 특정부위를, 서열번호 21과 22는 서열번호 14, 서열번호 23과 24는 서열번호 15, 서열번호 25와 26은 서열번호 16, 서열번호 27과 28은 서열번호 17, 서열번호 29와 30은 서열번호 18의 특정부위를 증폭하도록 제작되었다.
Each primer was prepared to amplify a specific site of the nucleotide sequence (SEQ ID NOS: 13-18) including the respective promoter sites, and is represented by SEQ ID NOs: 19-30. The primers set forth in SEQ ID NOs: 19 and 20 represent specific regions of the nucleotide sequence of SEQ ID NO: 13, SEQ ID NOs 21 and 22, SEQ ID NO: 14, SEQ ID NOs: 23 and 24, SEQ ID NO: 15, SEQ ID NOs: 25 and 26, SEQ ID NO: 16, SEQ ID NOs: 27 and 28 were designed to amplify a specific site of SEQ ID NO: 17, SEQ ID NOs: 29 and 30 of SEQ ID NO: 18.

4-2) 4-2) PCRPCR 및 다형성( And polymorphism ( polymorphismpolymorphism oror polymorphicpolymorphic patternpattern )의 발굴Excavation

PCR 혼합물(PCR mixture)은 20 ng genomic DNA, 10 mM Tris-HCl(pH 9.0), 40 mM KCl, 1.5 mM MgCl2, 250 μM dNTP, 10 pmole each primer, 1 unit Taq DNA polymerase가 포함되었으며, 총 반응용액은 20 ㎕로 하였다.PCR mixture contained 20 ng genomic DNA, 10 mM Tris-HCl (pH 9.0), 40 mM KCl, 1.5 mM MgCl 2 , 250 μM dNTP, 10 pmole each primer, 1 unit Taq DNA polymerase The reaction solution was 20 µl.

PCR 조건은 GeneAmp PCR System 2700(Applied Biosystems USA)을 이용하여 첫 번째 PCR은 초기 DNA 변성은 94℃ 5분, DNA 변성 94℃ 30초, 아닐링(annealing) 49.3℃ 30초, DNA 연장(DNA extension) 72℃에서 30초로 25회(cycle) 실행했으며, 최종 DNA 연장(DNA extension)은 72℃에서 7분간 실행하였다. PCR conditions were GeneAmp PCR System 2700 (Applied Biosystems USA), the first PCR, the initial DNA denaturation 94 5 minutes, DNA denaturation 94 ℃ 30 seconds, annealing 49.3 ℃ 30 seconds, DNA extension (DNA extension) 25 cycles were performed at 72 ° C. for 30 seconds, and the final DNA extension was performed at 72 ° C. for 7 minutes.

두 번째 PCR은 첫 번째 PCR 생성물 5 ㎕, 10 mM Tris-HCl(pH 9.0), 40 mM KCl, 1.5 mM MgCl2, 250 μM dNTP, 10 pmole each primer, 1 unit Taq DNA polymerase가 포함되었으며, 총 반응용액은 20 ㎕로 하여 첫 번째 PCR과 같은 조건으로 25회(cycle) 실행하였다. 두 번째 PCR 생성물은 2% 아가로스 겔(agarose gel)로 전기영동한 후 UV 엘루미네이터(UV eluminator)로 밴드(band)를 확인하였다(도 7).
The second PCR contained 5 μl of the first PCR product, 10 mM Tris-HCl (pH 9.0), 40 mM KCl, 1.5 mM MgCl 2 , 250 μM dNTP, 10 pmole each primer, 1 unit Taq DNA polymerase, total reaction The solution was 20 μl and 25 cycles were performed under the same conditions as the first PCR. The second PCR product was electrophoresed with a 2% agarose gel (agarose gel) and then confirmed the band (band) with a UV eluminator (UV eluminator) (Fig. 7).

4-3) 4-3) MedicagoMedicago truncatulatruncatula of MYBMYB 유사유전자 프로모터 염기서열을 이용한 콩 품종 간 다형성의 발굴 Development of Polymorphism Between Soybean Varieties Using Pseudogene Promoter Sequences

두과작물(荳科作物)의 모델 식물체인 Medicago truncatula의 게놈 DNA 서열 데이터베이스(genomic DNA sequencing database)의 염기서열을 이용하여 프라이머를 만들고, 콩의 게놈 DNA를 주형으로 하여 콩 품종간 다형성을 발굴하는 이유는 다음과 같다. 현재, NCBI GenBank 와 Phytozome(www.phytozome.net/)에 제시된 콩의 게놈 DNA 서열은 미국 에너지부(US DOE)의 Joint Genome Institute에서 수행되었던 게놈 프로젝트(genome sequencing project)의 결과로서 미국 콩 품종인 Williams82(PI518671)의 게놈 DNA 염기서열이다. 따라서 이 문헌의 게놈 DNA 서열 데이터베이스의 염기서열은 하나의 특정 콩 품종의 염기서열로서, 이를 기반으로 프라이머를 발굴하고 다른 콩 품종들과 비교하여 다양한 양적, 질적 형질과 관련된 유전체 수준에서의 다형성을 발굴하는데 활용하기에는 한계가 존재한다. Medicago , a model plant of legume crops The primers are prepared using the nucleotide sequence of the genomic DNA sequencing database of truncatula , and the reason for discovering polymorphism among soybean varieties using the genomic DNA of soybean as a template is as follows. Currently, the genomic DNA sequence of soybeans presented in NCBI GenBank and Phytozome ( www.phytozome.net/ ) is the result of a genome sequencing project conducted at the Joint Genome Institute of the US Department of Energy (US DOE). Genomic DNA sequence of Williams82 (PI518671). Thus, the nucleotide sequence of the genomic DNA sequence database in this document is the nucleotide sequence of one particular soybean cultivar, based on which it is possible to identify primers and to identify polymorphisms at the genome level related to various quantitative and qualitative traits compared to other soybean varieties. There is a limit to using it.

만약, Williams82 의 게놈 DNA 서열 데이터베이스로부터 본 실험에서 수행한 것과 같이 특정 유전자의 염기서열에 근거하여 프로모터 염기서열을 발굴하고 그 프로모터 부위를 증폭할 수 있는 프라이머를 작성하여 증폭된 패턴을 비교함으로써 다형성을 발굴하고자 한다면 Williams82라는 특정 콩 품종을 표준으로 여러 다양한 콩 품종을 비교하여야 한다. 이러한 방법으로는 콩 품종 간의 특정형질(표현형)과 유전체 수준에서의 다형성(유전자형)의 비교에 많은 제약과 한계를 가지게 된다. If, according to the experiment in Williams82's genomic DNA sequence database, the promoter sequence was identified based on the nucleotide sequence of a specific gene, a primer was prepared to amplify the promoter region, and the polymorphism was compared. If you want to dig, you should compare several different soybean varieties based on the specific bean variety Williams82. This approach has many limitations and limitations in comparing the specific (phenotype) and polymorphism (genotype) at the genome level between soybean varieties.

따라서 본 발명에서는 동일한 글리신(Glycine)속이며 콩(Glycine max)과는 유전적으로 매우 유사하다고 알려진 Medicago truncatula로부터 유사 유전자의 염기서열을 발굴하고, 그것에 근거한 프로모터 염기서열을 추출하고 프라이머를 작성한 후, 비교 유전체학의 기법을 통해 Medicago truncatula의 염기서열을 기준으로 콩 품종 간 다양성을 특정유전자의 프로모터부위의 다형성으로 비교하고자 하였다.
Therefore, in the present invention, the same glycine (Glycine) genus and soybean ( Glycine) max ) is known to be genetically very similar to Medicago Excavating the nucleotide sequence of the analogous gene from truncatula, and extracts the promoter nucleotide sequence based on it, and then create the primer, using the techniques of comparative genomics Medicago We tried to compare the diversity between soybean varieties based on the truncatula nucleotide sequence as a polymorphism of the promoter region of a specific gene.

상기 이유로 Medicago truncatula의 게놈 DNA 데이터베이스에서 발굴한 MYB 유사 유전자의 프로모터 부위를 증폭할 수 있는 프라이머를 작성한 후, 이를 콩 점무늬병에 대해 다양한 반응을 보이는 여러 콩 품종의 게놈 DNA를 주형으로 하였을 때 증폭되는 밴드 패턴에서 관찰되는 다형성을 NT SYS 분석하여 콩 품종 간 근연관계를 조사하였다. 이 NT SYS 분석에 사용된 밴드는 도 7 및 표 2에 제시되었다. Medicago for the above reasons A primer was prepared to amplify the promoter region of MYB- like gene extracted from truncatula 's genomic DNA database and observed in band pattern amplified when genomic DNA of various soybean varieties responding to soybean spot disease was used as a template. NT SYS analysis was performed to investigate the relationship between soybean varieties. The bands used for this NT SYS analysis are shown in FIG. 7 and Table 2.

Figure pat00002
Figure pat00002

콩 품종 간에 이러한 다형성을 보이는 것은 각각의 서로 다른 콩 품종의 게놈 DNA(genomic DNA)가 가지는 유전체 수준에서의 고유특성으로 볼 수 있다. 이 다형성을 분석한 결과 콩 점무늬병을 일으키는 균의 race에 대하여 다양한 반응을 보이는 품종 간의 근연 관계는 도 8에 나타난 바와 같다.This polymorphism among soybean varieties can be seen as a characteristic at the genome level of genomic DNA of different soybean varieties. As a result of analyzing the polymorphism, the relationship between the varieties which show various responses to the race of the bacteria which cause soybean spot disease is shown in FIG. 8.

콩 점무늬병균의 race에 반응하는 콩 품종 간의 차이를 비교한 표 1에 의하면 보광콩은 race Cs-2, 10, 14, 16, 19, 20 모두에 저항성을 보이고 금강콩은 Cs-10과 20 두 race에 감수성을 보이며, 청자콩3호는 Cs-10, 14, 19에 감수성을 보인 반면 대망콩, 다채콩, 태광콩은 대체로 콩 점무늬병에 감수성을 보였다. Table 1 compares the differences between the soybean varieties that respond to the race of soybean spotted germs. Bogwang soybeans are resistant to race Cs-2, 10, 14, 16, 19, and 20. Sensitive to race, Cheongja soybean 3 was susceptible to Cs-10, 14, 19, while Daemyung, Dachae, and Taekwang were generally susceptible to soy spot disease.

이러한 콩 점무늬병에 대한 품종 간 반응의 차이를 각 콩 품종이 보이는 표현형으로 하고 위에서 언급한 밴드패턴의 다형성을 각각의 콩 품종이 가지는 유전체 수준에서의 고유 특성으로 하여, 이러한 유전체 수준의 고유 특성에 근거한 근연관계와 표현형과의 관계를 비교하여 보면 6개의 콩 점무늬병균 race에 모두 저항성을 보이는 보광콩과 대체로 감수성을 보이는 태광콩, 다채콩, 대망콩은 유전적으로 거리가 먼 그룹으로 나누어지는 것을 관찰할 수 있으며, race에 따라 감수성과 저항성을 보이는 금강콩, 청자3호콩도 이들 저항성, 감수성 품종과는 서로 다른 그룹으로 분리되는 것을 관찰할 수 있다. 따라서, 이들 서열번호 19 내지 30로 기재되는 프라이머에 의해 나타난 유전체 수준의 고유특성을 분석하여 보면 특정 콩 품종이 콩 점무늬병균에 보이는 반응을 예측가능하게 하는 분자마커로 활용이 가능하다.
Based on the inherent characteristics of the genome level, the difference in the response between the varieties to the soybean spot disease is represented by the phenotype of each soybean variety, and the polymorphism of the band pattern mentioned above is inherent in the genome level of each soybean variety. Comparing the relationship between latex and phenotypes, we can observe that Bogwang beans, which are resistant to all six soybean spot germ races, and Taek, Soybean, and Daemang beans, which are generally susceptible, are divided into genetically distant groups. In addition, it can be observed that Kumgang beans and Cheongja 3 Ho beans, which are sensitive and resistant depending on race, are separated from these resistant and sensitive varieties. Therefore, by analyzing the intrinsic properties of the genome level shown by the primers described in SEQ ID NOs: 19 to 30, it can be utilized as a molecular marker for predicting the response of a specific bean variety to soybean spot bacteria.

이상으로 본 발명 내용의 특정부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 것은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.The specific parts of the present invention have been described in detail above, and it should be apparent to those skilled in the art that such specific descriptions are merely preferred embodiments, and thus the scope of the present invention is not limited thereto. will be. It is therefore intended that the scope of the invention be defined by the claims appended hereto and their equivalents.

<110> Konkuk University Industrial Cooperation Corp. <120> METHOD FOR DEVELOPING GENE SPECIFIC MOLECULAR MARKERS <130> P10-E414 <160> 30 <170> KopatentIn 1.71 <210> 1 <211> 684 <212> DNA <213> Glycine max <400> 1 gggtctttgg tcaccagaag aagatgaaaa acttttgagg catattacta agtacggtca 60 tggatgttgg agctcagttc ctaagcaagc aggtactcca acactgtata gtctatacca 120 ccccatttag cataaaaatc aagggaagaa aactgtagtt cattttcccg tcaatgtcct 180 ttattggcag gtttgcagag gtgcggcaaa agctgcaggc ttaggtggat caattattta 240 aggcctgatt tgaagagagg tacattttca caagaggagg aaaatctcat cattgaactt 300 catgcagtgc tagggaacag gtaaatctaa caatccttct ttacatgatt ttattagtct 360 ctgactctcg gccgatggat acctgttttc ttgtgattgg gtcatcctag atatcttgac 420 atggatatcc ttttgttttc ttcttctcag atggtctcaa attgcagcac aattgccagg 480 gaggactgac aatgaaataa agaatctgtg gaattcttgc ttaaagaaga aactcaggca 540 aagaggaata gaccctgtga cacataagcc actgtcagag gttgagaatg gagaggaggg 600 caaaacgagg agccaagaat tatccaatga actgaacctc ctgaattcag agagcttcaa 660 gtcagatgaa gggtcctatg agac 684 <210> 2 <211> 1001 <212> DNA <213> Glycine max <400> 2 gtttttgaat aatgaggact caagttagta agataacttc ttaggtaact aactttgtca 60 gcatatagta aaataattct gccatcagtt tttctaagta tcaatttttt ttatcttcag 120 tcacaagcat tttttttccc ttataatgtt ttcacttgat tatgatatca gcaaaggtgt 180 cccaccattc ctgcaagagg catcaatgct cacaccttcg aaaagacatg gtacactgtt 240 tcaagtttca accccatttt tttcaccttg ccaaaataaa taaaccttcc ctcctttcaa 300 ctccgaccta tatacaacaa gaagtcctat ttcacattgt tgaatctcta tcagatagat 360 caaccatata attgtaattc gacccttaaa tacatttttt ttaaaataaa gaaaatacaa 420 ggaaccttgt tgactatgac ccttctcatg gggccttgct cttatattag ttcaacttct 480 tttctcagct gccagttcat tttccttctt catatcatct ctctcgctgt cacattctct 540 ctatctatct cagccactcc aatagctttg gttcactgcc acccctgctg acatttttct 600 cattggaata aacaaacttt gtgttaactg aaaaaggttt ttaagggaaa aagaaaaaat 660 tacaaaatgg gaaggcactc ttgttgttac aagcagaagc ttaggaaggg tctttggtct 720 cctgaggagg atgaaaaact tctgaggcat ataacaaagt atggtcatgg atgttggagt 780 tctgtgccta agcaagcagg taattaatca aattatccaa ctaagcctcc tttaatctcc 840 tttgtaacaa aaagagaaat ttttttattc atctctctgt gaatgatatg aattggcagg 900 tttgcaaagg tgtggtaaga gctgcaggct taggtggatc aattacttaa ggcctgattt 960 aaagagagga acattctcac aagaagaaga aaaccttatc a 1001 <210> 3 <211> 723 <212> DNA <213> Glycine max <400> 3 tggatgttaa gaaaggtggg tctgtagtac aagcacaagt gaagttgcag aagcataacg 60 aaaaggagat gggcatgaga aaaggtccat gggcggttga ggaggacacc attctggtca 120 attacatcgc cacacacggt gaaggccact ggaattccgt ggcacgatgt gcaggcatgc 180 atgcatctta attataattt aatttctgca tgtgccaagt aataatggta tatatgttaa 240 ttatgagatt tatcaattac aggtctaagg aggagtggga agagttgcag attaaggtgg 300 ctaaactact tgcgcccaga cgtgcggcgt ggaaatatca cactccaaga acaaatatta 360 attctcgacc ttcactctcg ctggggcaac aggtatggta taaaaatatt ccactctctc 420 tctctctcta tatatatata ttaatttgtt ttataaggtt ggatgtacac atatataaca 480 tagtatgaat gaatgaatgt tttttgatag gtggtcaaag attgctcaac agctgccagg 540 aagaacagac aacgaaataa agaactattg gaggaccaga gtgataaaac aagcgaagca 600 gctaaagtgc gatgtgaata gcaaacagtt cagagacacg ttgcgttacg tttggatgcc 660 gcgcttgctg gagcggcttc agcccacatc acaagcactg gagccaaacc aaagtggact 720 tgt 723 <210> 4 <211> 506 <212> DNA <213> Glycine max <400> 4 agacctgaag gggctaagga aaattagaag gacacacaag tataaaggcg gtgaaataaa 60 agagaaagac aagaagaaga catgggaaga ccaccttgtt gtgacaaaga aggggtcaag 120 aaagggcctt ggactcctga agaagacatc atattggtgt cttatattca ggaacatggt 180 cctggaaatt ggagggcagt tcctgccaaa acaggttaat taattagccc tacactcaat 240 ttgatgatta ttttgcataa tattggttct tgttctttgt tgtgtttatt agatcattat 300 ttaaagaagt ttctgattga aatattggcc atttgggttt cattgtttta tctttggatc 360 tgaattgatt tttccatttt ggggttattt tcagggttgt caagatgcag caagagttgc 420 agacttagat ggactaatta cctgaggcca ggaatcaaac ggggcaactt cacagaacaa 480 gaggagaaga tgataatcca tcttca 506 <210> 5 <211> 544 <212> DNA <213> Glycine max <400> 5 aaaaagntgg ngctccaccg cggtggcggc cgctctagaa ctagtggatc ccccgggctg 60 caggaattcg gcacgaggat acaaggtcac ttagggaaca agaatataaa agaaggaaaa 120 agaagacgac atagcaaagc ctagaaacat gggtcaccat tcttgctgca accaacagaa 180 ggttaaaaga ggactttggt ctcctgagga agacgaaaaa ctcatcagat acattactac 240 tcatggatat ggctgttggg gtgaagttcc agaaaaagct gggcttctaa ggtgtggcaa 300 agagttgtcg cttgagatgg attaattatt taagacccga tattaaaaga ggcaggttta 360 cacctgagga ggagaagtta attataactc ttcacggggt cgtgggaaac agatgggctc 420 acattgcaag ccacttgcct gggtccgaac tgacaatnga ataaagaact attgggactc 480 atgggttana aangnangat aagaaaagac ntccgtgtct tcaaccaccn antgcacaaa 540 gtnt 544 <210> 6 <211> 434 <212> DNA <213> Glycine max <400> 6 tctaactcct tttgtgctat ataaagaagt agaaaagtca ccagtgttta tcactgttcc 60 cactttctcc aaaaatggga agatcaccat gctgtgacaa ggtgggtttg aagaagggac 120 catggacgcc agaggaagat cagaagctct tggcttatat tgaagaacat ggccatggaa 180 gctggcgtgc tttgccagca aaagctggta aataatctta tatacatgtt gatatataaa 240 tatcttgtaa ttaaagtaaa acttgccgtg taatttgtga agtgaattag ttgctggcta 300 ctgtgttcag gacttcagag gtgtggcaaa agctgcagat tgagatggac taattatcta 360 aggcctgata ttaagagggg gaaattcagt atgcaagaag aacaaaccat cattcaactt 420 catgctctct tagg 434 <210> 7 <211> 107 <212> DNA <213> Medicago truncatula <400> 7 agctgtaggc ttaggtggat taattactta aggcctgatt taaaaagagg tacattttca 60 caagaagaag aaaatctcat cattgaactt cattcagtac tagggaa 107 <210> 8 <211> 128 <212> DNA <213> Medicago truncatula <400> 8 tggtcacaaa ttgctgcaca attgccaggg aggactgata atgaaataaa gaatctttgg 60 aattcttgct taaagaagaa actgagacaa aagggtatag accctgtcac tcataaacca 120 ctttctga 128 <210> 9 <211> 127 <212> DNA <213> Medicago truncatula <400> 9 aggagaagtg gtaaaagttg tagattaagg tggttaaact acttgcgtcc cgatttacgt 60 cgtggaaata tcacacttca agaacagata ttgattcttg acctccactc tcgctggggc 120 aataggt 127 <210> 10 <211> 124 <212> DNA <213> Medicago truncatula <400> 10 acatgggaag accaccttgt tgtgacaaag aaggtgttaa aaaaggacca tggactcctg 60 aagaagatat catacttgtt acttatatac aagaacatgg tcctggaaat tggagggctg 120 ttcc 124 <210> 11 <211> 140 <212> DNA <213> Medicago truncatula <400> 11 agaaagatgg gtcaccattc atgctgtaat caacagaagg ttaagagagg cctttggtca 60 cctgaagaag atgagaaact cattagatac attactactc atggttatgg ttgctggagt 120 gaagttcctg agaaagctgg 140 <210> 12 <211> 137 <212> DNA <213> Medicago truncatula <400> 12 aaaatgggac gttcaccatg ttgtgacaaa gttggtttaa agaaaggtcc atggactcca 60 gaagaagatc aaaaactctt agcttatatt gatgaacatg gtcatggaag ttggcgtgct 120 ttgcccgcta aagctgg 137 <210> 13 <211> 2059 <212> DNA <213> Medicago truncatula <400> 13 gaaaatgtac ctctttttaa atcaggcctt aagtaattaa tccacctaag cctacagctc 60 ttaccacatc tttgaagacc tatgccatgc catgccatgc caataaaata cattatatat 120 caacaacagt ttcttctcta atctcataat tatatgctaa aaggagattg aaatattaaa 180 atttggatta tatataaata tatatacctg cttgcttagg aactgaactc caacatccat 240 gaccatattt agtaatatga ttcaaaagtt tttcatcctc ctcaggtgac catagacctt 300 tcctaagctt ctgcttgtag caacaagagt gtcttcccat ttgtagtttg tttgtggttt 360 ggtccctcaa acttaaaaat acaatgaagt gcgaaagttt ttgataaaca gaaagattgt 420 tggatttgtg cagcaataaa caaagaccgt gacaggtaaa atatgagtga gagagataga 480 gagagagaga ttatattatg aagtgtgaaa gatggaaaat gaagtggcag ctgagaaaat 540 gagttgaggc cccatgaatt atgtcatata gtcattaagg taccttctat ttatcttatt 600 ttttcctttt ttgagaatat acgtgtcctt atgtttcttt atttattttt tctatctttt 660 tatttaaaat gtgtataatg acaagtgaaa tagaatacat catgcattaa aatcaaatta 720 tttgttcatt agattagata tcttgtaatg taataaaaaa gtgaaatgtt tatagaatgg 780 aaggtcattt cgtcatgctt tttccatttt tttttttata aacgttattt tattttttaa 840 agggaaagac ttaatggtac tacgatgcat gagatcaggg tcgtcttaaa caatttgttg 900 gccccgtttt aatcttataa attggccccc ggataaaaat agaaagaaaa aaaacaattt 960 tttaaagtaa attatgataa catcccaata atgtaaataa catcaaaaag tgattttatg 1020 ttcaaatcac taacatcaaa ataaacgagc cactcttcca acattttttg aatagtaacc 1080 acattttcaa gaactccaac acctagcggg agttgaatcc ctgtccatgc ggtcttgtac 1140 gtaacgctct accaccgaag tattcttaac aatttgtcaa gttctctctt tcacctctat 1200 ataacactta ctataggacc ttacatataa aaaaaaaaat atgggcccat agcctgtcag 1260 agcttgatta acgcattaat gaaaaaaaat aatcaaatta caaacttgcc ctttagcttg 1320 actttgattt caaaaagaaa agttggagtt ttttatccaa accaaaaggt gttcaatgct 1380 aaaacacaca ttctattttc ttgatgggag tttcataaca aaactatata tatatatata 1440 tatatatata tatatatata tataagtttt taatagcctt tttaaattgt agaacaagtt 1500 tttatggatg acagttaggg aatacaacca cttttgtaat tacaacaaac caattaaaaa 1560 actaaaattt ctagatgatt gaaatatttt attttttgaa aaataaagtt tatgtgagtt 1620 aggtttcaat aattcataag gatcagagta tacaatattt gtctgaacaa agtcttagcg 1680 ttgataatga aagttgaaca tatgtccata ctatgtatac aaatttctta taagaatgta 1740 tataaatttt tcattaacaa agtcttaacg ctgataatga aaattgaata cgtgtctata 1800 ctatttatga atcaacttct taacaattga atgacaattt tatgcatttt tattttattt 1860 ttctcgagaa tatattcttt cacttttaaa caaagcttta atagtaaccg aaaaaaacaa 1920 agctttaatt atggacaact aattaactat ttggctcata tgttgtttca ctgtctaata 1980 ctaacgacaa tgagtttatt aaatctcatt aacgtcacaa ctattccacc ggcactgtat 2040 ggtatggtta tggtataat 2059 <210> 14 <211> 2059 <212> DNA <213> Medicago truncatula <400> 14 caaagattct ttatttcatt atcagtcctc cctggcaatt gtgcagcaat ttgtgaccat 60 ctaagaaaac acatcatatg catgtcaata aggtttgaaa aataaaaaga atgatccaac 120 aaccacataa caattaaaaa atacgccaga gtctaacgca agtggttggt gtgtcgtgtg 180 tgagtgttgt aaactctggt aaatcatact taaaaaagaa ggattgaatt taattaccta 240 ttccctagta ctgaatgaag ttcaatgatg agattttctt cttcttgtga aaatgtacct 300 ctttttaaat caggccttaa gtaattaatc cacctaagcc tacagctctt accacatctt 360 tgaagaccta tgccatgcca tgccatgcca ataaaataca ttatatatca acaacagttt 420 cttctctaat ctcataatta tatgctaaaa ggagattgaa atattaaaat ttggattata 480 tataaatata tatacctgct tgcttaggaa ctgaactcca acatccatga ccatatttag 540 taatatgatt caaaagtttt tcatcctcct caggtgacca tagacctttc ctaagcttct 600 gcttgtagca acaagagtgt cttcccattt gtagtttgtt tgtggtttgg tccctcaaac 660 ttaaaaatac aatgaagtgc gaaagttttt gataaacaga aagattgttg gatttgtgca 720 gcaataaaca aagaccgtga caggtaaaat atgagtgaga gagatagaga gagagagatt 780 atattatgaa gtgtgaaaga tggaaaatga agtggcagct gagaaaatga gttgaggccc 840 catgaattat gtcatatagt cattaaggta ccttctattt atcttatttt ttcctttttt 900 gagaatatac gtgtccttat gtttctttat ttattttttc tatcttttta tttaaaatgt 960 gtataatgac aagtgaaata gaatacatca tgcattaaaa tcaaattatt tgttcattag 1020 attagatatc ttgtaatgta ataaaaaagt gaaatgttta tagaatggaa ggtcatttcg 1080 tcatgctttt tccatttttt tttttataaa cgttatttta ttttttaaag ggaaagactt 1140 aatggtacta cgatgcatga gatcagggtc gtcttaaaca atttgttggc cccgttttaa 1200 tcttataaat tggcccccgg ataaaaatag aaagaaaaaa aacaattttt taaagtaaat 1260 tatgataaca tcccaataat gtaaataaca tcaaaaagtg attttatgtt caaatcacta 1320 acatcaaaat aaacgagcca ctcttccaac attttttgaa tagtaaccac attttcaaga 1380 actccaacac ctagcgggag ttgaatccct gtccatgcgg tcttgtacgt aacgctctac 1440 caccgaagta ttcttaacaa tttgtcaagt tctctctttc acctctatat aacacttact 1500 ataggacctt acatataaaa aaaaaaatat gggcccatag cctgtcagag cttgattaac 1560 gcattaatga aaaaaaataa tcaaattaca aacttgccct ttagcttgac tttgatttca 1620 aaaagaaaag ttggagtttt ttatccaaac caaaaggtgt tcaatgctaa aacacacatt 1680 ctattttctt gatgggagtt tcataacaaa actatatata tatatatata tatatatata 1740 tatatatata taagttttta atagcctttt taaattgtag aacaagtttt tatggatgac 1800 agttagggaa tacaaccact tttgtaatta caacaaacca attaaaaaac taaaatttct 1860 agatgattga aatattttat tttttgaaaa ataaagttta tgtgagttag gtttcaataa 1920 ttcataagga tcagagtata caatatttgt ctgaacaaag tcttagcgtt gataatgaaa 1980 gttgaacata tgtccatact atgtatacaa atttcttata agaatgtata taaatttttc 2040 attaacaaag tcttaacgc 2059 <210> 15 <211> 2059 <212> DNA <213> Medicago truncatula <400> 15 cgtaaatcgg gacgcaagta gtttaaccac cttaatctac aacttttacc acttctcctc 60 aaacctgtat aattaattag ttttgtttag aatagattat gagaatcaat aagctattca 120 tgcagctatg tcataagcta ataaataaaa gagctagaag aaaatatata aatatataca 180 tgcctgcaga agatgcaagg gtattccagt gaccttcacc gtgtattgta atgtaatcaa 240 ccagaatggt gtcctcttct aacgtccaag gaccttttct tacccctgtc tcattttcct 300 ttgcagaccc acctttctga accttaatat ccatacctct catgtatgtg tagctctcaa 360 taattgttac tgaaattaaa agtgatttag ttttgtgaaa ggaagaacaa acagtatgaa 420 atatatatga gaaacgaaga aacgtgtaag attttgattt aattgatggt ttcacttatt 480 gggggcatgt ggagttattg tgtatatata ataatagagt cggataagga taggtatact 540 tcaaggtttg cactagtcta caaaatataa attaaaaggg tacggaatag tgacgacttg 600 gtacacgaat aatgcaccag tttgagtaaa tttaattaat attactactt taggattaag 660 atggaaccaa gcttatagtt tggggtttga ctggttgact cttttgttta tatttttggt 720 aagtcatgcg catggaaata ttgatgtcag tgaatactct tttcacaatc taaactgatt 780 tggctttagc tctatcagct cactgttaag aaagacaaat tttactaaaa aataataata 840 gaataaattg ttattgtaaa tttgtaatct catattgtta ttccctaact aataattaaa 900 ctcatgtgat taataaattt taattgagaa ggattcttta gaagatttga attcaaattc 960 atattcgggc agatggagac attaatgaaa gtaaaaaaaa aataaaaatt agagagaaca 1020 atcaatttag ttattatact atcattttct catcaatttg gtcttaaaat taataaattt 1080 aagtaaaaaa tccataattt aaaaaaaaaa aaaaaaaaaa gggacaagcc aatctaaatt 1140 gaggagagtc aaacttggac cttaaaagta atagacgttc aaaccaaaac caactaaagt 1200 gagtttaaaa gaaattccat aaattttact ctcatccatc aatttgatga tctctcaatt 1260 aattagttta tgtatcaaat tgatgatgaa attatagtac aagacatttc acttgatttt 1320 aaaagtttag gaatcaaatt gacaattgat agtttatgaa ctaaatttac ttattattta 1380 tattatgtgt gagattaccg tgtaatattt gttttttttc aaagcaacta tagattgttg 1440 gttaataaag gagatttttt ccttcttttt cctactaatc cagaatggca ttgacggtag 1500 aatgagaagc aacactaaca cagcagccac caccttttca cacaagtgca taaatttata 1560 tcattcacga ttcttaagtg tttgtttgtt tcatgtaatg ttgcatcctg agaattacat 1620 ttgggcacta aaaagcttag tagtgaatag aaagacgaag aaatagactt gttgtgatta 1680 actcattaat taacgcagga ctagaaggaa gaaaattagt tgcgataatc attgcacgtt 1740 ttcactttga ccaaaacact aagaattgga aacaatccca tcgcagtcgc acgatcatgt 1800 ggatttggtt aaatacttcg tattgtctca ataataaaca aaaaattggt caaaatgccc 1860 ataagacacg ttcaagctcc aagttttcaa ggacatcata ccatcgacga caatgtacgg 1920 tgaattgttc cctccatacc caagttatat aagtaaaaaa aatatcaaag aaagttcatg 1980 tatttgaatc aaattttaaa tcttctatac ctcaactcaa tgtctgtcat tcaattggct 2040 aactattaaa cttggtaat 2059 <210> 16 <211> 2050 <212> DNA <213> Medicago truncatula <400> 16 aggagtccat ggtccttttt taacaccttc tttgtcacaa caaggtggtc ttcccatgtt 60 tctttgtttc tcttttactt ttagtaacac ttgtatatgt tgccactaat ttctattcta 120 tagacctttt tcttcctctt cctctctcgg tgtatgatca cttatcttta atttttagtt 180 ctctctaaaa cctcttgatt tgataggttt caaaaggcaa gtgtccaagc ctaacctttc 240 catggtgtaa atatatagct aagaaaatag ggtgtattta gcataagcta ggatttttta 300 tttttttatt tttttttaaa gataagctag gaaactgact taaaaaagta gagaaaaaat 360 aaagagtcaa aatttgacag caaagagcat taactgaagg aaggaaaaag ctaaattatt 420 tactatagtt atgttgtgta ccactcaaaa ccgcgtagag cattgaatgt gtagctctat 480 tacactggga aagctcaatt ttatttcagc ttttaaagtt tctataaatt aacacaaaca 540 tgtcattaat tgtaaatttg tgatatagct gacttttgca agaaagctag taattaagct 600 atcaccatta tgtctttcta tttgcctacc tggtgatcac caatgaacaa gccctttcta 660 gatactttaa cttgtctata aaatcaatta attgcattta tattttgtta attagacagt 720 gactaaaact gacacccttg cttcattcta gaaagggata gctgatctat ttgcattatt 780 gtagtagaat tctaatatcc catattttgt taaagaaaaa tatactagta taatttaaga 840 atggtatttt tctttaagag aaaatatact agtaatatcg cattgttact gatttttgtg 900 aaataaaata ttagtcgttt aatgtttgtg cacgattatt aaggaaatga ttaattgtgt 960 tgatttcaac ggtaaaatta gtcatttact acaacaccct tattaattgt agttagtgga 1020 gtagttaagt aggatgaaat tcaataaata agggtataat agtgaaaaaa aataataaat 1080 gctgcattgg tattgtaaag tgtcaattat tttgaaaaaa agaaaaaatg ctaaagagat 1140 aataagtggg aaacggatgg agtatttttt atttaagaga aaaaaaatag gattatcaaa 1200 taaaataaac gtgtttaaat tttgggtttt gatgccctga gggcactttg ttaaggatac 1260 aaaaggggat gcttaacaag aagtgatctt tgttaagtaa aaaaccttta aggaattcca 1320 taagagatgc tctaagagca ctcgttagca cttcccttaa ataaaattat cactttataa 1380 caaaaaattt cagagattac aacttgtaaa taaaattaaa tatgtttcaa atgagtagtt 1440 gttccgagta gcttttccat aaaactaatt tttcataact ggttctaaaa aaaatatttt 1500 cattttgata atgaaatata gaataacttc tgctttaaaa aaaaaaaatc tccatcaatt 1560 tggtcttaga gttatcaccc tcttttttaa ttaatcttcg gactataaaa atatatacta 1620 atgagtttgt ctgacatgta caatattaca catgatatgg tagctaaaaa taacaacttt 1680 ttatttaaaa attatatact ccaatactaa ttttgaactt cttatttgag cttccaaaat 1740 ggaccgacaa tatactctta cgaatctaaa agacctccag aaggactttt agactctttt 1800 agaggcctca tcgtcctcca taagggctat gaggcccaag gcgcgccctc cccagggcgt 1860 cgactcaatc tgcttctagg aacctctaga aagccgccca aatacttaga tacccctgtt 1920 atttactgcc taagtaacca caaatcagac ccatagagag ctataaatac caacccttga 1980 gagccttctc aaggcatgac caatacaata caaaccctaa tacgattatt gtacttttag 2040 caagtacaca 2050 <210> 17 <211> 2767 <212> DNA <213> Medicago truncatula <400> 17 ctgatttttc cgtccttctc acactgtcac tcatattatg ttttagagga ttctactcga 60 agttattata aaataaaaat ttaattaaaa tgttatatcc atttttttag accacactat 120 caatgttaaa ttaaaagttc ttatttagta ctccctccgt ctctaaataa tagtcgttta 180 aggttgatgc acagttatta aggaaatgat taattgtgtt gattttgatg gtaaaattag 240 tactaaaaca cccttattaa ttgtagttag tgtgcagtag ttaaattgga taaagttcaa 300 taaataaggg tattataatg aaaaaataaa ataaatgctg cattgatatt ctaaagtgac 360 aattattttg agaaaaagaa aaataggtaa agagacaatt attgtgagac ggagggagta 420 gatcgacgtt ttttctaaat attttagttc ttttttggaa aaactaaaag aataatatta 480 agttatggat catgctaact tatgttctta ggacacatgt taagaatttc attagtggta 540 aatatttact atgaaaaatt aattcttaac ttcttgaaaa atacaagagt ttcttaacat 600 gtgtctattt tagatatctt aacatgtgtt ttaaaaggac aagtttgtat aagttattaa 660 caaaagcttg cacaaaaagt ggctagggga gaaatacaag agtttccaca atccatgaca 720 aatgagtgaa cacatgaaaa acaaattaca caaatgagcc acaaacaaaa acccaactct 780 taatgagtgt catgtcggtt ccttattaat aaataaaaaa tagaatattt gtgtgtcatg 840 tatgaagatg gtttccaggg tggatttgga cttaaaatat tagtgaggca caattttttt 900 tgttgaataa ttaaataaaa ctaaatttaa taagaataaa aagtgtttgt ttatgtttgt 960 gttgtgcgtt tggtgagaga aagaacaatg aaaaaggctt actgaagtga gaagtgaggg 1020 gaaaggtttt actgtgtact tgtgttttgg agtgttcgtg gcgcagtttg gttcgatttt 1080 gagactaaaa gtcatttgaa ccgtaagata aaaaaacatg cggtttggtt tggtttggtt 1140 gacttttaaa ataaattcag aaccaaatcg atgcggtttg ggttggatcg gttggtgcgg 1200 ttttttttac tagacaatac aattttttgt ttccaatttt aaaatcaagt taaaaagtta 1260 aaacacaaca tacttctggc aatgtttccg acaatggttt ttaatttcat acaacattaa 1320 aatttcattt tcactaaaca acatatacca aattaaaaat gtggacaaaa aagtaattct 1380 attatgtaag aaatgtaaaa gattaagatt ttatcatttt tttttaagga agattttatc 1440 attctttaaa agttcaaatt gcacataaat acatttttga aataaaaagc aacttaacaa 1500 aagaaaatat atgtcattta taaaagtttc catttagttt ctatgagtat tggcgtagat 1560 gacatatatt taattagtgt ttttcttatg ttgcggtttg attcggttca gttggtaaaa 1620 taaaaactgg aaaccgaacc aaaccatgcg gtagagtaaa aaagtgattt gaaattcaaa 1680 ccaaatgcag ttttttgcag tttcggttga ttcagtttgc ggtttttcta tagaattagt 1740 ttggctttga tcaccctatt gttttggact gggctgagct tgtggaaaga aataaaaaat 1800 cagcttgggg gtggtgtggc gcttgccaca ccaggacctg ttcaggtccg cccctgaggg 1860 ttccataaga tttgacaaga gtatcatatt tgagagtgtc atatgtgctt gtcacatgat 1920 tctttattaa ttatccatga tttccttaaa tccatagtct tccgaaagtt tgttataaat 1980 aaatgtattt ttagttaaga agcaaacgaa aaacaaataa aatgcatata aattttgacc 2040 ttttaaaaat acacacaaaa actaaatgat atcatattgg acatgtcaag gtatagttac 2100 ttctctgtta gaagcaccat gaagataaat acacacaaga aaactaaatg atatcatttt 2160 gatggattat ttcacgaaaa gtagatgaaa gtgtagtaat aatctacttt ttgcataaat 2220 tcaaaattaa tacttgcttc ctaattccta tctctttcac gtagctatag taaataaata 2280 ttatccactt attaataagt actgatgatg tataatgacg ttgttgaata tatagttggc 2340 agacaggaaa caaccagcaa caatactcct tctttctttt ttcagcttcc tctcgttatg 2400 tatatatttt ggagagactt gttatatatg gtaaaatgtg aagaattttg ttatgtaata 2460 ctacacatgt acgtagaaaa ttgctagaat aaagttgatg gaacgtcact ttagggttag 2520 atggagatat gggtcctaca tgcaggttgt aaatgtcgac ttcagttccc tcagttttaa 2580 aagaaggaaa gatagaaaga gaaagagata actattgcat tgcacttgca cttgcacttg 2640 cacacataca ctgatatatg aatgaaggta caatttacta aacaaaaaga gacaggcata 2700 gaacaagaga aagatgggtc accattcatg ctgtaatcaa cagaaggtta agagaggcct 2760 ttggtca 2767 <210> 18 <211> 2054 <212> DNA <213> Medicago truncatula <400> 18 cagatgtcca tggccctttc tttaaaccaa ccttttcaca acatggtgat ctccccattg 60 gaaatgttct aatgaaaaac tatatagtaa attgtgtata tggttgagaa gttggaggag 120 aaacttggaa gagaaagaga aagaaaggag aatatataag ttgatcaagt agctatgtac 180 aagaaattaa tgagatgggc agagaagaat ttgtcagcgg cataaaaggg ataagaaatt 240 aaattgatac tcatcaatat aaatcattat acgaggagaa tagtaaaact ttaatttaac 300 tgcagtatag tacagcacat tcactacact ttgcgcattt tttgctgcat catttatttg 360 cagtacattc tacatttata tgcatataaa ttgggtggtt tttatgatag acaaacttac 420 ataaacattt tttttggaaa gatatctact ttttttttaa ggaaaggaaa gatatctact 480 taacggcgag taaatatatt tttttaaaca ggtaaaatga taatattatc acaaaaaaaa 540 acacaatatc accaaatcga tttagcttaa aaaaacacaa tatctacttt agtacaagat 600 atgcgaggag gaaaatagtt ttatatcacc aaatcgaaag gataaaacat aacaattcag 660 tcaagaccca aacaagcaaa gggttgtttc aaccacatca aatgaccaaa aggaaaatta 720 acattttgag ctttcagcca ccaataggta gaaactttca ctttatccat cagcttcaga 780 atagatttag ctttatggct caggctacgg tacatgacct caatgggtct cctaccgtag 840 gtgacttgac tttttttttt tttacaaaat tgatgtcaac cattggatgt gcttgaaaac 900 ttttgaagac catagtatta ttatactctt taaacattag attattttca cactatgttc 960 catcatcttt ctctttccct ctccatatct cttactcgcc caacaacaac aacaacgcga 1020 tgcaccgcca ccgaaaaatc acaacgacaa tgcgccggaa aatcacaaca acaacgacga 1080 atttttggaa atcttaatcc aatcctttca acccaaaatt gcagaaaaca acattcatta 1140 aactcaaatt tcatttaatc taattcacct gaaaacaaaa ttgcagaaaa tattgatttc 1200 ttaattattc aattcattca acccaaagtt cacatattca tcactaaact cagatgaaag 1260 tgattaaatc cgtcgccaga ccaaatgtta cacaacaaaa caatcaaaat cggaatggaa 1320 aatctcacag aactcagatc tggagaggga tggtgtttaa gttcagatgt gaacacaatc 1380 tggtcaatgg aaaattacga atgaaaatag aataaaaaga acaaaaaaag atgtgttggt 1440 gttaaaaaaa aaaacgacga tttgtgttgg aggtataaca atcaacagaa agtgcagcaa 1500 caacaatgga gttgctacag tacacgtctc tcgcttagat ctaccaaatg aaaaaaatat 1560 atatagtgta gaaggattat ggtaagatca gtgtttttcg tcaatctaac cgcaacacat 1620 gtcatttttg ttataaaata aataaataaa acagtctttt ttaatgtctc ctcccgtggg 1680 agacctattc aagtctccta ccataaacgg cgccgagatt atgtctctaa gtctaaccat 1740 gatgatgtta tggacgacga tgataatgat ggagacatga ctgttttttt ttcttagaat 1800 aaaagagaag agtaatttag aagtaaagag aagagtaatt tagaataaaa gaaagtaatt 1860 cggtgtggga ggtatatagt aagcattttg atccaaagtt aatttacttt tatccaatgg 1920 ttcatattta ttttgccaaa aaaaaaaaag ccatgtctcc tacaggaaac agagccttag 1980 ctttattgtt aaagagtctg tttctctttt ctgtccacaa cattgaaaaa caacaaagcc 2040 atattagctg caaa 2054 <210> 19 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 19 tccacctaag cctacagctc 20 <210> 20 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 20 ccggtggaat agttgtgacg 20 <210> 21 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 21 atttcattat cagtcctccc 20 <210> 22 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 22 aacgctaaga ctttgttcag 20 <210> 23 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 23 gtaaatcggg acgcaagtag 20 <210> 24 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 24 atggagggaa caattcaccg 20 <210> 25 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 25 cacaacaagg tggtcttccc 20 <210> 26 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 26 tttgggcggc tttctagagg 20 <210> 27 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 27 tgcacaaaaa gtggctaggg 20 <210> 28 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 28 cagtgtatgt gtgcaagtgc 20 <210> 29 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 29 tcacaacatg gtgatctccc 20 <210> 30 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> {rimer <400> 30 actatatacc tcccacaccg 20 <110> Konkuk University Industrial Cooperation Corp. <120> METHOD FOR DEVELOPING GENE SPECIFIC MOLECULAR MARKERS <130> P10-E414 <160> 30 <170> KopatentIn 1.71 <210> 1 <211> 684 <212> DNA <213> Glycine max <400> 1 gggtctttgg tcaccagaag aagatgaaaa acttttgagg catattacta agtacggtca 60 tggatgttgg agctcagttc ctaagcaagc aggtactcca acactgtata gtctatacca 120 ccccatttag cataaaaatc aagggaagaa aactgtagtt cattttcccg tcaatgtcct 180 ttattggcag gtttgcagag gtgcggcaaa agctgcaggc ttaggtggat caattattta 240 aggcctgatt tgaagagagg tacattttca caagaggagg aaaatctcat cattgaactt 300 catgcagtgc tagggaacag gtaaatctaa caatccttct ttacatgatt ttattagtct 360 ctgactctcg gccgatggat acctgttttc ttgtgattgg gtcatcctag atatcttgac 420 atggatatcc ttttgttttc ttcttctcag atggtctcaa attgcagcac aattgccagg 480 gaggactgac aatgaaataa agaatctgtg gaattcttgc ttaaagaaga aactcaggca 540 aagaggaata gaccctgtga cacataagcc actgtcagag gttgagaatg gagaggaggg 600 caaaacgagg agccaagaat tatccaatga actgaacctc ctgaattcag agagcttcaa 660 gtcagatgaa gggtcctatg agac 684 <210> 2 <211> 1001 <212> DNA <213> Glycine max <400> 2 gtttttgaat aatgaggact caagttagta agataacttc ttaggtaact aactttgtca 60 gcatatagta aaataattct gccatcagtt tttctaagta tcaatttttt ttatcttcag 120 tcacaagcat tttttttccc ttataatgtt ttcacttgat tatgatatca gcaaaggtgt 180 cccaccattc ctgcaagagg catcaatgct cacaccttcg aaaagacatg gtacactgtt 240 tcaagtttca accccatttt tttcaccttg ccaaaataaa taaaccttcc ctcctttcaa 300 ctccgaccta tatacaacaa gaagtcctat ttcacattgt tgaatctcta tcagatagat 360 caaccatata attgtaattc gacccttaaa tacatttttt ttaaaataaa gaaaatacaa 420 ggaaccttgt tgactatgac ccttctcatg gggccttgct cttatattag ttcaacttct 480 tttctcagct gccagttcat tttccttctt catatcatct ctctcgctgt cacattctct 540 ctatctatct cagccactcc aatagctttg gttcactgcc acccctgctg acatttttct 600 cattggaata aacaaacttt gtgttaactg aaaaaggttt ttaagggaaa aagaaaaaat 660 tacaaaatgg gaaggcactc ttgttgttac aagcagaagc ttaggaaggg tctttggtct 720 cctgaggagg atgaaaaact tctgaggcat ataacaaagt atggtcatgg atgttggagt 780 tctgtgccta agcaagcagg taattaatca aattatccaa ctaagcctcc tttaatctcc 840 tttgtaacaa aaagagaaat ttttttattc atctctctgt gaatgatatg aattggcagg 900 tttgcaaagg tgtggtaaga gctgcaggct taggtggatc aattacttaa ggcctgattt 960 aaagagagga acattctcac aagaagaaga aaaccttatc a 1001 <210> 3 <211> 723 <212> DNA <213> Glycine max <400> 3 tggatgttaa gaaaggtggg tctgtagtac aagcacaagt gaagttgcag aagcataacg 60 aaaaggagat gggcatgaga aaaggtccat gggcggttga ggaggacacc attctggtca 120 attacatcgc cacacacggt gaaggccact ggaattccgt ggcacgatgt gcaggcatgc 180 atgcatctta attataattt aatttctgca tgtgccaagt aataatggta tatatgttaa 240 ttatgagatt tatcaattac aggtctaagg aggagtggga agagttgcag attaaggtgg 300 ctaaactact tgcgcccaga cgtgcggcgt ggaaatatca cactccaaga acaaatatta 360 attctcgacc ttcactctcg ctggggcaac aggtatggta taaaaatatt ccactctctc 420 tctctctcta tatatatata ttaatttgtt ttataaggtt ggatgtacac atatataaca 480 tagtatgaat gaatgaatgt tttttgatag gtggtcaaag attgctcaac agctgccagg 540 aagaacagac aacgaaataa agaactattg gaggaccaga gtgataaaac aagcgaagca 600 gctaaagtgc gatgtgaata gcaaacagtt cagagacacg ttgcgttacg tttggatgcc 660 gcgcttgctg gagcggcttc agcccacatc acaagcactg gagccaaacc aaagtggact 720 tgt 723 <210> 4 <211> 506 <212> DNA <213> Glycine max <400> 4 agacctgaag gggctaagga aaattagaag gacacacaag tataaaggcg gtgaaataaa 60 agagaaagac aagaagaaga catgggaaga ccaccttgtt gtgacaaaga aggggtcaag 120 aaagggcctt ggactcctga agaagacatc atattggtgt cttatattca ggaacatggt 180 cctggaaatt ggagggcagt tcctgccaaa acaggttaat taattagccc tacactcaat 240 ttgatgatta ttttgcataa tattggttct tgttctttgt tgtgtttatt agatcattat 300 ttaaagaagt ttctgattga aatattggcc atttgggttt cattgtttta tctttggatc 360 tgaattgatt tttccatttt ggggttattt tcagggttgt caagatgcag caagagttgc 420 agacttagat ggactaatta cctgaggcca ggaatcaaac ggggcaactt cacagaacaa 480 gaggagaaga tgataatcca tcttca 506 <210> 5 <211> 544 <212> DNA <213> Glycine max <400> 5 aaaaagntgg ngctccaccg cggtggcggc cgctctagaa ctagtggatc ccccgggctg 60 caggaattcg gcacgaggat acaaggtcac ttagggaaca agaatataaa agaaggaaaa 120 agaagacgac atagcaaagc ctagaaacat gggtcaccat tcttgctgca accaacagaa 180 ggttaaaaga ggactttggt ctcctgagga agacgaaaaa ctcatcagat acattactac 240 tcatggatat ggctgttggg gtgaagttcc agaaaaagct gggcttctaa ggtgtggcaa 300 agagttgtcg cttgagatgg attaattatt taagacccga tattaaaaga ggcaggttta 360 cacctgagga ggagaagtta attataactc ttcacggggt cgtgggaaac agatgggctc 420 acattgcaag ccacttgcct gggtccgaac tgacaatnga ataaagaact attgggactc 480 atgggttana aangnangat aagaaaagac ntccgtgtct tcaaccaccn antgcacaaa 540 gtnt 544 <210> 6 <211> 434 <212> DNA <213> Glycine max <400> 6 tctaactcct tttgtgctat ataaagaagt agaaaagtca ccagtgttta tcactgttcc 60 cactttctcc aaaaatggga agatcaccat gctgtgacaa ggtgggtttg aagaagggac 120 catggacgcc agaggaagat cagaagctct tggcttatat tgaagaacat ggccatggaa 180 gctggcgtgc tttgccagca aaagctggta aataatctta tatacatgtt gatatataaa 240 tatcttgtaa ttaaagtaaa acttgccgtg taatttgtga agtgaattag ttgctggcta 300 ctgtgttcag gacttcagag gtgtggcaaa agctgcagat tgagatggac taattatcta 360 aggcctgata ttaagagggg gaaattcagt atgcaagaag aacaaaccat cattcaactt 420 catgctctct tagg 434 <210> 7 <211> 107 <212> DNA <213> Medicago truncatula <400> 7 agctgtaggc ttaggtggat taattactta aggcctgatt taaaaagagg tacattttca 60 caagaagaag aaaatctcat cattgaactt cattcagtac tagggaa 107 <210> 8 <211> 128 <212> DNA <213> Medicago truncatula <400> 8 tggtcacaaa ttgctgcaca attgccaggg aggactgata atgaaataaa gaatctttgg 60 aattcttgct taaagaagaa actgagacaa aagggtatag accctgtcac tcataaacca 120 ctttctga 128 <210> 9 <211> 127 <212> DNA <213> Medicago truncatula <400> 9 aggagaagtg gtaaaagttg tagattaagg tggttaaact acttgcgtcc cgatttacgt 60 cgtggaaata tcacacttca agaacagata ttgattcttg acctccactc tcgctggggc 120 aataggt 127 <210> 10 <211> 124 <212> DNA <213> Medicago truncatula <400> 10 acatgggaag accaccttgt tgtgacaaag aaggtgttaa aaaaggacca tggactcctg 60 aagaagatat catacttgtt acttatatac aagaacatgg tcctggaaat tggagggctg 120 ttcc 124 <210> 11 <211> 140 <212> DNA <213> Medicago truncatula <400> 11 agaaagatgg gtcaccattc atgctgtaat caacagaagg ttaagagagg cctttggtca 60 cctgaagaag atgagaaact cattagatac attactactc atggttatgg ttgctggagt 120 gaagttcctg agaaagctgg 140 <210> 12 <211> 137 <212> DNA <213> Medicago truncatula <400> 12 aaaatgggac gttcaccatg ttgtgacaaa gttggtttaa agaaaggtcc atggactcca 60 gaagaagatc aaaaactctt agcttatatt gatgaacatg gtcatggaag ttggcgtgct 120 ttgcccgcta aagctgg 137 <210> 13 <211> 2059 <212> DNA <213> Medicago truncatula <400> 13 gaaaatgtac ctctttttaa atcaggcctt aagtaattaa tccacctaag cctacagctc 60 ttaccacatc tttgaagacc tatgccatgc catgccatgc caataaaata cattatatat 120 caacaacagt ttcttctcta atctcataat tatatgctaa aaggagattg aaatattaaa 180 atttggatta tatataaata tatatacctg cttgcttagg aactgaactc caacatccat 240 gaccatattt agtaatatga ttcaaaagtt tttcatcctc ctcaggtgac catagacctt 300 tcctaagctt ctgcttgtag caacaagagt gtcttcccat ttgtagtttg tttgtggttt 360 ggtccctcaa acttaaaaat acaatgaagt gcgaaagttt ttgataaaca gaaagattgt 420 tggatttgtg cagcaataaa caaagaccgt gacaggtaaa atatgagtga gagagataga 480 gagagagaga ttatattatg aagtgtgaaa gatggaaaat gaagtggcag ctgagaaaat 540 gagttgaggc cccatgaatt atgtcatata gtcattaagg taccttctat ttatcttatt 600 ttttcctttt ttgagaatat acgtgtcctt atgtttcttt atttattttt tctatctttt 660 tatttaaaat gtgtataatg acaagtgaaa tagaatacat catgcattaa aatcaaatta 720 tttgttcatt agattagata tcttgtaatg taataaaaaa gtgaaatgtt tatagaatgg 780 aaggtcattt cgtcatgctt tttccatttt tttttttata aacgttattt tattttttaa 840 agggaaagac ttaatggtac tacgatgcat gagatcaggg tcgtcttaaa caatttgttg 900 gccccgtttt aatcttataa attggccccc ggataaaaat agaaagaaaa aaaacaattt 960 tttaaagtaa attatgataa catcccaata atgtaaataa catcaaaaag tgattttatg 1020 ttcaaatcac taacatcaaa ataaacgagc cactcttcca acattttttg aatagtaacc 1080 acattttcaa gaactccaac acctagcggg agttgaatcc ctgtccatgc ggtcttgtac 1140 gtaacgctct accaccgaag tattcttaac aatttgtcaa gttctctctt tcacctctat 1200 ataacactta ctataggacc ttacatataa aaaaaaaaat atgggcccat agcctgtcag 1260 agcttgatta acgcattaat gaaaaaaaat aatcaaatta caaacttgcc ctttagcttg 1320 actttgattt caaaaagaaa agttggagtt ttttatccaa accaaaaggt gttcaatgct 1380 aaaacacaca ttctattttc ttgatgggag tttcataaca aaactatata tatatatata 1440 tatatatata tatatatata tataagtttt taatagcctt tttaaattgt agaacaagtt 1500 tttatggatg acagttaggg aatacaacca cttttgtaat tacaacaaac caattaaaaa 1560 actaaaattt ctagatgatt gaaatatttt attttttgaa aaataaagtt tatgtgagtt 1620 aggtttcaat aattcataag gatcagagta tacaatattt gtctgaacaa agtcttagcg 1680 ttgataatga aagttgaaca tatgtccata ctatgtatac aaatttctta taagaatgta 1740 tataaatttt tcattaacaa agtcttaacg ctgataatga aaattgaata cgtgtctata 1800 ctatttatga atcaacttct taacaattga atgacaattt tatgcatttt tattttattt 1860 ttctcgagaa tatattcttt cacttttaaa caaagcttta atagtaaccg aaaaaaacaa 1920 agctttaatt atggacaact aattaactat ttggctcata tgttgtttca ctgtctaata 1980 ctaacgacaa tgagtttatt aaatctcatt aacgtcacaa ctattccacc ggcactgtat 2040 ggtatggtta tggtataat 2059 <210> 14 <211> 2059 <212> DNA <213> Medicago truncatula <400> 14 caaagattct ttatttcatt atcagtcctc cctggcaatt gtgcagcaat ttgtgaccat 60 ctaagaaaac acatcatatg catgtcaata aggtttgaaa aataaaaaga atgatccaac 120 aaccacataa caattaaaaa atacgccaga gtctaacgca agtggttggt gtgtcgtgtg 180 tgagtgttgt aaactctggt aaatcatact taaaaaagaa ggattgaatt taattaccta 240 ttccctagta ctgaatgaag ttcaatgatg agattttctt cttcttgtga aaatgtacct 300 ctttttaaat caggccttaa gtaattaatc cacctaagcc tacagctctt accacatctt 360 tgaagaccta tgccatgcca tgccatgcca ataaaataca ttatatatca acaacagttt 420 cttctctaat ctcataatta tatgctaaaa ggagattgaa atattaaaat ttggattata 480 tataaatata tatacctgct tgcttaggaa ctgaactcca acatccatga ccatatttag 540 taatatgatt caaaagtttt tcatcctcct caggtgacca tagacctttc ctaagcttct 600 gcttgtagca acaagagtgt cttcccattt gtagtttgtt tgtggtttgg tccctcaaac 660 ttaaaaatac aatgaagtgc gaaagttttt gataaacaga aagattgttg gatttgtgca 720 gcaataaaca aagaccgtga caggtaaaat atgagtgaga gagatagaga gagagagatt 780 atattatgaa gtgtgaaaga tggaaaatga agtggcagct gagaaaatga gttgaggccc 840 catgaattat gtcatatagt cattaaggta ccttctattt atcttatttt ttcctttttt 900 gagaatatac gtgtccttat gtttctttat ttattttttc tatcttttta tttaaaatgt 960 gtataatgac aagtgaaata gaatacatca tgcattaaaa tcaaattatt tgttcattag 1020 attagatatc ttgtaatgta ataaaaaagt gaaatgttta tagaatggaa ggtcatttcg 1080 tcatgctttt tccatttttt tttttataaa cgttatttta ttttttaaag ggaaagactt 1140 aatggtacta cgatgcatga gatcagggtc gtcttaaaca atttgttggc cccgttttaa 1200 tcttataaat tggcccccgg ataaaaatag aaagaaaaaa aacaattttt taaagtaaat 1260 tatgataaca tcccaataat gtaaataaca tcaaaaagtg attttatgtt caaatcacta 1320 acatcaaaat aaacgagcca ctcttccaac attttttgaa tagtaaccac attttcaaga 1380 actccaacac ctagcgggag ttgaatccct gtccatgcgg tcttgtacgt aacgctctac 1440 caccgaagta ttcttaacaa tttgtcaagt tctctctttc acctctatat aacacttact 1500 ataggacctt acatataaaa aaaaaaatat gggcccatag cctgtcagag cttgattaac 1560 gcattaatga aaaaaaataa tcaaattaca aacttgccct ttagcttgac tttgatttca 1620 aaaagaaaag ttggagtttt ttatccaaac caaaaggtgt tcaatgctaa aacacacatt 1680 ctattttctt gatgggagtt tcataacaaa actatatata tatatatata tatatatata 1740 tatatatata taagttttta atagcctttt taaattgtag aacaagtttt tatggatgac 1800 agttagggaa tacaaccact tttgtaatta caacaaacca attaaaaaac taaaatttct 1860 agatgattga aatattttat tttttgaaaa ataaagttta tgtgagttag gtttcaataa 1920 ttcataagga tcagagtata caatatttgt ctgaacaaag tcttagcgtt gataatgaaa 1980 gttgaacata tgtccatact atgtatacaa atttcttata agaatgtata taaatttttc 2040 attaacaaag tcttaacgc 2059 <210> 15 <211> 2059 <212> DNA <213> Medicago truncatula <400> 15 cgtaaatcgg gacgcaagta gtttaaccac cttaatctac aacttttacc acttctcctc 60 aaacctgtat aattaattag ttttgtttag aatagattat gagaatcaat aagctattca 120 tgcagctatg tcataagcta ataaataaaa gagctagaag aaaatatata aatatataca 180 tgcctgcaga agatgcaagg gtattccagt gaccttcacc gtgtattgta atgtaatcaa 240 ccagaatggt gtcctcttct aacgtccaag gaccttttct tacccctgtc tcattttcct 300 ttgcagaccc acctttctga accttaatat ccatacctct catgtatgtg tagctctcaa 360 taattgttac tgaaattaaa agtgatttag ttttgtgaaa ggaagaacaa acagtatgaa 420 atatatatga gaaacgaaga aacgtgtaag attttgattt aattgatggt ttcacttatt 480 gggggcatgt ggagttattg tgtatatata ataatagagt cggataagga taggtatact 540 tcaaggtttg cactagtcta caaaatataa attaaaaggg tacggaatag tgacgacttg 600 gtacacgaat aatgcaccag tttgagtaaa tttaattaat attactactt taggattaag 660 atggaaccaa gcttatagtt tggggtttga ctggttgact cttttgttta tatttttggt 720 aagtcatgcg catggaaata ttgatgtcag tgaatactct tttcacaatc taaactgatt 780 tggctttagc tctatcagct cactgttaag aaagacaaat tttactaaaa aataataata 840 gaataaattg ttattgtaaa tttgtaatct catattgtta ttccctaact aataattaaa 900 ctcatgtgat taataaattt taattgagaa ggattcttta gaagatttga attcaaattc 960 atattcgggc agatggagac attaatgaaa gtaaaaaaaa aataaaaatt agagagaaca 1020 atcaatttag ttattatact atcattttct catcaatttg gtcttaaaat taataaattt 1080 aagtaaaaaa tccataattt aaaaaaaaaa aaaaaaaaaa gggacaagcc aatctaaatt 1140 gaggagagtc aaacttggac cttaaaagta atagacgttc aaaccaaaac caactaaagt 1200 gagtttaaaa gaaattccat aaattttact ctcatccatc aatttgatga tctctcaatt 1260 aattagttta tgtatcaaat tgatgatgaa attatagtac aagacatttc acttgatttt 1320 aaaagtttag gaatcaaatt gacaattgat agtttatgaa ctaaatttac ttattattta 1380 tattatgtgt gagattaccg tgtaatattt gttttttttc aaagcaacta tagattgttg 1440 gttaataaag gagatttttt ccttcttttt cctactaatc cagaatggca ttgacggtag 1500 aatgagaagc aacactaaca cagcagccac caccttttca cacaagtgca taaatttata 1560 tcattcacga ttcttaagtg tttgtttgtt tcatgtaatg ttgcatcctg agaattacat 1620 ttgggcacta aaaagcttag tagtgaatag aaagacgaag aaatagactt gttgtgatta 1680 actcattaat taacgcagga ctagaaggaa gaaaattagt tgcgataatc attgcacgtt 1740 ttcactttga ccaaaacact aagaattgga aacaatccca tcgcagtcgc acgatcatgt 1800 ggatttggtt aaatacttcg tattgtctca ataataaaca aaaaattggt caaaatgccc 1860 ataagacacg ttcaagctcc aagttttcaa ggacatcata ccatcgacga caatgtacgg 1920 tgaattgttc cctccatacc caagttatat aagtaaaaaa aatatcaaag aaagttcatg 1980 tatttgaatc aaattttaaa tcttctatac ctcaactcaa tgtctgtcat tcaattggct 2040 aactattaaa cttggtaat 2059 <210> 16 <211> 2050 <212> DNA <213> Medicago truncatula <400> 16 aggagtccat ggtccttttt taacaccttc tttgtcacaa caaggtggtc ttcccatgtt 60 tctttgtttc tcttttactt ttagtaacac ttgtatatgt tgccactaat ttctattcta 120 tagacctttt tcttcctctt cctctctcgg tgtatgatca cttatcttta atttttagtt 180 ctctctaaaa cctcttgatt tgataggttt caaaaggcaa gtgtccaagc ctaacctttc 240 catggtgtaa atatatagct aagaaaatag ggtgtattta gcataagcta ggatttttta 300 tttttttatt tttttttaaa gataagctag gaaactgact taaaaaagta gagaaaaaat 360 aaagagtcaa aatttgacag caaagagcat taactgaagg aaggaaaaag ctaaattatt 420 tactatagtt atgttgtgta ccactcaaaa ccgcgtagag cattgaatgt gtagctctat 480 tacactggga aagctcaatt ttatttcagc ttttaaagtt tctataaatt aacacaaaca 540 tgtcattaat tgtaaatttg tgatatagct gacttttgca agaaagctag taattaagct 600 atcaccatta tgtctttcta tttgcctacc tggtgatcac caatgaacaa gccctttcta 660 gatactttaa cttgtctata aaatcaatta attgcattta tattttgtta attagacagt 720 gactaaaact gacacccttg cttcattcta gaaagggata gctgatctat ttgcattatt 780 gtagtagaat tctaatatcc catattttgt taaagaaaaa tatactagta taatttaaga 840 atggtatttt tctttaagag aaaatatact agtaatatcg cattgttact gatttttgtg 900 aaataaaata ttagtcgttt aatgtttgtg cacgattatt aaggaaatga ttaattgtgt 960 tgatttcaac ggtaaaatta gtcatttact acaacaccct tattaattgt agttagtgga 1020 gtagttaagt aggatgaaat tcaataaata agggtataat agtgaaaaaa aataataaat 1080 gctgcattgg tattgtaaag tgtcaattat tttgaaaaaa agaaaaaatg ctaaagagat 1140 aataagtggg aaacggatgg agtatttttt atttaagaga aaaaaaatag gattatcaaa 1200 taaaataaac gtgtttaaat tttgggtttt gatgccctga gggcactttg ttaaggatac 1260 aaaaggggat gcttaacaag aagtgatctt tgttaagtaa aaaaccttta aggaattcca 1320 taagagatgc tctaagagca ctcgttagca cttcccttaa ataaaattat cactttataa 1380 caaaaaattt cagagattac aacttgtaaa taaaattaaa tatgtttcaa atgagtagtt 1440 gttccgagta gcttttccat aaaactaatt tttcataact ggttctaaaa aaaatatttt 1500 cattttgata atgaaatata gaataacttc tgctttaaaa aaaaaaaatc tccatcaatt 1560 tggtcttaga gttatcaccc tcttttttaa ttaatcttcg gactataaaa atatatacta 1620 atgagtttgt ctgacatgta caatattaca catgatatgg tagctaaaaa taacaacttt 1680 ttatttaaaa attatatact ccaatactaa ttttgaactt cttatttgag cttccaaaat 1740 ggaccgacaa tatactctta cgaatctaaa agacctccag aaggactttt agactctttt 1800 agaggcctca tcgtcctcca taagggctat gaggcccaag gcgcgccctc cccagggcgt 1860 cgactcaatc tgcttctagg aacctctaga aagccgccca aatacttaga tacccctgtt 1920 atttactgcc taagtaacca caaatcagac ccatagagag ctataaatac caacccttga 1980 gagccttctc aaggcatgac caatacaata caaaccctaa tacgattatt gtacttttag 2040 caagtacaca 2050 <210> 17 <211> 2767 <212> DNA <213> Medicago truncatula <400> 17 ctgatttttc cgtccttctc acactgtcac tcatattatg ttttagagga ttctactcga 60 agttattata aaataaaaat ttaattaaaa tgttatatcc atttttttag accacactat 120 caatgttaaa ttaaaagttc ttatttagta ctccctccgt ctctaaataa tagtcgttta 180 aggttgatgc acagttatta aggaaatgat taattgtgtt gattttgatg gtaaaattag 240 tactaaaaca cccttattaa ttgtagttag tgtgcagtag ttaaattgga taaagttcaa 300 taaataaggg tattataatg aaaaaataaa ataaatgctg cattgatatt ctaaagtgac 360 aattattttg agaaaaagaa aaataggtaa agagacaatt attgtgagac ggagggagta 420 gatcgacgtt ttttctaaat attttagttc ttttttggaa aaactaaaag aataatatta 480 agttatggat catgctaact tatgttctta ggacacatgt taagaatttc attagtggta 540 aatatttact atgaaaaatt aattcttaac ttcttgaaaa atacaagagt ttcttaacat 600 gtgtctattt tagatatctt aacatgtgtt ttaaaaggac aagtttgtat aagttattaa 660 caaaagcttg cacaaaaagt ggctagggga gaaatacaag agtttccaca atccatgaca 720 aatgagtgaa cacatgaaaa acaaattaca caaatgagcc acaaacaaaa acccaactct 780 taatgagtgt catgtcggtt ccttattaat aaataaaaaa tagaatattt gtgtgtcatg 840 tatgaagatg gtttccaggg tggatttgga cttaaaatat tagtgaggca caattttttt 900 tgttgaataa ttaaataaaa ctaaatttaa taagaataaa aagtgtttgt ttatgtttgt 960 gttgtgcgtt tggtgagaga aagaacaatg aaaaaggctt actgaagtga gaagtgaggg 1020 gaaaggtttt actgtgtact tgtgttttgg agtgttcgtg gcgcagtttg gttcgatttt 1080 gagactaaaa gtcatttgaa ccgtaagata aaaaaacatg cggtttggtt tggtttggtt 1140 gacttttaaa ataaattcag aaccaaatcg atgcggtttg ggttggatcg gttggtgcgg 1200 ttttttttac tagacaatac aattttttgt ttccaatttt aaaatcaagt taaaaagtta 1260 aaacacaaca tacttctggc aatgtttccg acaatggttt ttaatttcat acaacattaa 1320 aatttcattt tcactaaaca acatatacca aattaaaaat gtggacaaaa aagtaattct 1380 attatgtaag aaatgtaaaa gattaagatt ttatcatttt tttttaagga agattttatc 1440 attctttaaa agttcaaatt gcacataaat acatttttga aataaaaagc aacttaacaa 1500 aagaaaatat atgtcattta taaaagtttc catttagttt ctatgagtat tggcgtagat 1560 gacatatatt taattagtgt ttttcttatg ttgcggtttg attcggttca gttggtaaaa 1620 taaaaactgg aaaccgaacc aaaccatgcg gtagagtaaa aaagtgattt gaaattcaaa 1680 ccaaatgcag ttttttgcag tttcggttga ttcagtttgc ggtttttcta tagaattagt 1740 ttggctttga tcaccctatt gttttggact gggctgagct tgtggaaaga aataaaaaat 1800 cagcttgggg gtggtgtggc gcttgccaca ccaggacctg ttcaggtccg cccctgaggg 1860 ttccataaga tttgacaaga gtatcatatt tgagagtgtc atatgtgctt gtcacatgat 1920 tctttattaa ttatccatga tttccttaaa tccatagtct tccgaaagtt tgttataaat 1980 aaatgtattt ttagttaaga agcaaacgaa aaacaaataa aatgcatata aattttgacc 2040 ttttaaaaat acacacaaaa actaaatgat atcatattgg acatgtcaag gtatagttac 2100 ttctctgtta gaagcaccat gaagataaat acacacaaga aaactaaatg atatcatttt 2160 gatggattat ttcacgaaaa gtagatgaaa gtgtagtaat aatctacttt ttgcataaat 2220 tcaaaattaa tacttgcttc ctaattccta tctctttcac gtagctatag taaataaata 2280 ttatccactt attaataagt actgatgatg tataatgacg ttgttgaata tatagttggc 2340 agacaggaaa caaccagcaa caatactcct tctttctttt ttcagcttcc tctcgttatg 2400 tatatatttt ggagagactt gttatatatg gtaaaatgtg aagaattttg ttatgtaata 2460 ctacacatgt acgtagaaaa ttgctagaat aaagttgatg gaacgtcact ttagggttag 2520 atggagatat gggtcctaca tgcaggttgt aaatgtcgac ttcagttccc tcagttttaa 2580 aagaaggaaa gatagaaaga gaaagagata actattgcat tgcacttgca cttgcacttg 2640 cacacataca ctgatatatg aatgaaggta caatttacta aacaaaaaga gacaggcata 2700 gaacaagaga aagatgggtc accattcatg ctgtaatcaa cagaaggtta agagaggcct 2760 ttggtca 2767 <210> 18 <211> 2054 <212> DNA <213> Medicago truncatula <400> 18 cagatgtcca tggccctttc tttaaaccaa ccttttcaca acatggtgat ctccccattg 60 gaaatgttct aatgaaaaac tatatagtaa attgtgtata tggttgagaa gttggaggag 120 aaacttggaa gagaaagaga aagaaaggag aatatataag ttgatcaagt agctatgtac 180 aagaaattaa tgagatgggc agagaagaat ttgtcagcgg cataaaaggg ataagaaatt 240 aaattgatac tcatcaatat aaatcattat acgaggagaa tagtaaaact ttaatttaac 300 tgcagtatag tacagcacat tcactacact ttgcgcattt tttgctgcat catttatttg 360 cagtacattc tacatttata tgcatataaa ttgggtggtt tttatgatag acaaacttac 420 ataaacattt tttttggaaa gatatctact ttttttttaa ggaaaggaaa gatatctact 480 taacggcgag taaatatatt tttttaaaca ggtaaaatga taatattatc acaaaaaaaa 540 acacaatatc accaaatcga tttagcttaa aaaaacacaa tatctacttt agtacaagat 600 atgcgaggag gaaaatagtt ttatatcacc aaatcgaaag gataaaacat aacaattcag 660 tcaagaccca aacaagcaaa gggttgtttc aaccacatca aatgaccaaa aggaaaatta 720 acattttgag ctttcagcca ccaataggta gaaactttca ctttatccat cagcttcaga 780 atagatttag ctttatggct caggctacgg tacatgacct caatgggtct cctaccgtag 840 gtgacttgac tttttttttt tttacaaaat tgatgtcaac cattggatgt gcttgaaaac 900 ttttgaagac catagtatta ttatactctt taaacattag attattttca cactatgttc 960 catcatcttt ctctttccct ctccatatct cttactcgcc caacaacaac aacaacgcga 1020 tgcaccgcca ccgaaaaatc acaacgacaa tgcgccggaa aatcacaaca acaacgacga 1080 atttttggaa atcttaatcc aatcctttca acccaaaatt gcagaaaaca acattcatta 1140 aactcaaatt tcatttaatc taattcacct gaaaacaaaa ttgcagaaaa tattgatttc 1200 ttaattattc aattcattca acccaaagtt cacatattca tcactaaact cagatgaaag 1260 tgattaaatc cgtcgccaga ccaaatgtta cacaacaaaa caatcaaaat cggaatggaa 1320 aatctcacag aactcagatc tggagaggga tggtgtttaa gttcagatgt gaacacaatc 1380 tggtcaatgg aaaattacga atgaaaatag aataaaaaga acaaaaaaag atgtgttggt 1440 gttaaaaaaa aaaacgacga tttgtgttgg aggtataaca atcaacagaa agtgcagcaa 1500 caacaatgga gttgctacag tacacgtctc tcgcttagat ctaccaaatg aaaaaaatat 1560 atatagtgta gaaggattat ggtaagatca gtgtttttcg tcaatctaac cgcaacacat 1620 gtcatttttg ttataaaata aataaataaa acagtctttt ttaatgtctc ctcccgtggg 1680 agacctattc aagtctccta ccataaacgg cgccgagatt atgtctctaa gtctaaccat 1740 gatgatgtta tggacgacga tgataatgat ggagacatga ctgttttttt ttcttagaat 1800 aaaagagaag agtaatttag aagtaaagag aagagtaatt tagaataaaa gaaagtaatt 1860 cggtgtggga ggtatatagt aagcattttg atccaaagtt aatttacttt tatccaatgg 1920 ttcatattta ttttgccaaa aaaaaaaaag ccatgtctcc tacaggaaac agagccttag 1980 ctttattgtt aaagagtctg tttctctttt ctgtccacaa cattgaaaaa caacaaagcc 2040 atattagctg caaa 2054 <210> 19 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 19 tccacctaag cctacagctc 20 <210> 20 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 20 ccggtggaat agttgtgacg 20 <210> 21 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 21 atttcattat cagtcctccc 20 <210> 22 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 22 aacgctaaga ctttgttcag 20 <210> 23 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 23 gtaaatcggg acgcaagtag 20 <210> 24 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 24 atggagggaa caattcaccg 20 <210> 25 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 25 cacaacaagg tggtcttccc 20 <210> 26 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 26 tttgggcggc tttctagagg 20 <210> 27 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 27 tgcacaaaaa gtggctaggg 20 <210> 28 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 28 cagtgtatgt gtgcaagtgc 20 <210> 29 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Primer <400> 29 tcacaacatg gtgatctccc 20 <210> 30 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> {rimer <400> 30 actatatacc tcccacaccg 20

Claims (14)

(1) 콩 점무늬병에 대한 반응성이 서로 다른 콩의 품종별 게놈 DNA(genomic DNA)를 추출하는 단계;
(2) Medicago truncatula의 DNA 염기서열 데이터베이스로부터 콩(Glycine max)의 MYB 전사조절유전자의 염기서열과 유사한 유전자를 찾아내는 단계;
(3) 상기 Medicago truncatula의 DNA 염기서열 데이터베이스로부터 상기 (2) 단계에서 찾아낸 유전자의 프로모터 부위를 발굴하는 단계;
(4) 상기 프로모터의 특정 부위를 증폭할 수 있는 PCR 프라이머(primer)를 제작하는 단계;
(5) 상기 (1) 단계의 게놈 DNA(genomic DNA)를 주형으로 하고, (4) 단계의 프라이머를 이용하여 특정 유전자의 프로모터 부위를 증폭하는 단계; 및
(6) 상기 증폭된 특정 유전자의 프로모터 부위에서 다형성을 관찰, 분석하여 계통 간 분자마커로 사용될 수 있는 패턴을 확인하는 단계;
를 포함하는 분자마커 개발 방법.
(1) extracting genomic DNA (genomic DNA) according to varieties of beans having different reactivity to soybean spot disease;
(2) Medicago finding a gene similar to the nucleotide sequence of the MYB transcriptional regulator of soybean ( Glycine max ) from the DNA sequence database of truncatula ;
(3) the Medicago digging out the promoter region of the gene found in step (2) from the DNA sequence database of truncatula ;
(4) preparing a PCR primer capable of amplifying a specific site of the promoter;
(5) using the genomic DNA of step (1) as a template and amplifying a promoter region of a specific gene using the primer of step (4); And
(6) observing and analyzing polymorphism at the promoter region of the amplified specific gene to identify a pattern that can be used as a molecular marker between lines;
Molecular marker development method comprising a.
제 1항에 있어서,
상기 콩 품종은 보광콩, 장원콩, 금강콩, 청자콩3호, 안평콩, 대망콩, 다채콩 및 태광콩으로 이루어진 군에서 선택되는 1종 이상인 것을 특징으로 하는 분자마커 개발 방법.
The method of claim 1,
The bean varieties are Bogwang bean, Jangwon bean, Geumgang bean, Cheongja bean No. 3, Anpyeong bean, Daemangong bean, Dachae bean and Taekwang bean development method of molecular marker, characterized in that at least one selected from the group consisting of.
제 1항에 있어서,
상기 콩(Glycine max)의 MYB 전자조절유전자는 서열번호 1 내지 6으로 기재된 염기서열 중에서 선택된 1 이상인 것을 특징으로 하는 분자마커 개발 방법.
The method of claim 1,
MYB electron control gene of the soybean ( Glycine max ) is a molecular marker development method, characterized in that at least one selected from the base sequences described in SEQ ID NO: 1 to 6.
제 1항에 있어서,
상기 콩(Glycine max)의 MYB 전자조절유전자의 염기서열과 유사한 유전자는 서열번호 7 내지 12로 기재된 염기서열 중에서 선택된 1 이상인 것을 특징으로 하는 분자마커 개발 방법.
The method of claim 1,
Glycine max ) genes similar to the nucleotide sequence of MYB electron control gene of the molecular marker development method, characterized in that at least one selected from the nucleotide sequence shown in SEQ ID NO: 7 to 12.
제 1항에 있어서,
상기 (3) 단계는 (2) 단계에서 찾아낸 유전자 염기서열의 5' 방향 상위 1.5 ~ 2 Kb 부위에서 프로모터를 발굴하는 것을 특징으로 하는 분자마커 개발 방법.
The method of claim 1,
Step (3) is a method for developing a molecular marker, characterized in that the excavation of the promoter in the 1.5 ~ 2 Kb region of the 5 'direction of the gene sequence found in step (2).
제 1항에 있어서,
상기 (4) 단계는 특정 유전자의 프로모터가 포함되는 개시코돈으로부터 5' 방향으로 10 Kb 내부에서 복수의 프라이머를 제작하는 것을 특징으로 하는 분자마커 개발방법.
The method of claim 1,
Step (4) is a method for developing a molecular marker, characterized in that for producing a plurality of primers within 10 Kb in the 5 'direction from the start codon including the promoter of a specific gene.
제 1항에 있어서,
상기 (3) 단계에서 발굴한 프로모터 부위는 서열번호 13 내지 18로 기재된 염기서열 중에서 선택된 1 이상인 것을 특징으로 하는 분자마커 개발 방법.
The method of claim 1,
Promoter site discovered in step (3) is a molecular marker development method, characterized in that at least one selected from the base sequences described in SEQ ID NO: 13 to 18.
제 7항에 있어서,
상기 서열번호 13으로 기재되는 프로모터 부위를 증폭할 수 있는 프라이머는 서열번호 19 및 20로 기재되는 프라이머 쌍인 것을 특징으로 하는 분자마커 개발방법.
The method of claim 7, wherein
Primer capable of amplifying the promoter region described in SEQ ID NO: 13 is a molecular marker development method, characterized in that the primer pair described in SEQ ID NO: 19 and 20.
제 7항에 있어서,
상기 서열번호 14로 기재되는 프로모터 부위를 증폭할 수 있는 프라이머는 서열번호 21 및 22로 기재되는 프라이머 쌍인 것을 특징으로 하는 분자마커 개발방법.
The method of claim 7, wherein
Primer capable of amplifying the promoter region described in SEQ ID NO: 14 is a molecular marker development method, characterized in that the primer pair described in SEQ ID NO: 21 and 22.
제 7항에 있어서,
상기 서열번호 15로 기재되는 프로모터 부위를 증폭할 수 있는 프라이머는 서열번호 23 및 24로 기재되는 프라이머 쌍인 것을 특징으로 하는 분자마커 개발방법.
The method of claim 7, wherein
Primer capable of amplifying the promoter region described in SEQ ID NO: 15 is a molecular marker development method, characterized in that the primer pair described in SEQ ID NO: 23 and 24.
제 7항에 있어서,
상기 서열번호 16으로 기재되는 프로모터 부위를 증폭할 수 있는 프라이머는 서열번호 25 및 26로 기재되는 프라이머 쌍인 것을 특징으로 하는 분자마커 개발방법.
The method of claim 7, wherein
Primer capable of amplifying the promoter region described in SEQ ID NO: 16 is a molecular marker development method, characterized in that the primer pair described in SEQ ID NO: 25 and 26.
제 7항에 있어서,
상기 서열번호 17로 기재되는 프로모터 부위를 증폭할 수 있는 프라이머는 서열번호 27 및 28로 기재되는 프라이머 쌍인 것을 특징으로 하는 분자마커 개발방법.
The method of claim 7, wherein
Primer capable of amplifying the promoter region described in SEQ ID NO: 17 is a molecular marker development method, characterized in that the primer pair described in SEQ ID NO: 27 and 28.
제 7항에 있어서,
상기 서열번호 18로 기재되는 프로모터 부위를 증폭할 수 있는 프라이머는 서열번호 29 및 30으로 기재되는 프라이머 쌍인 것을 특징으로 하는 분자마커 개발방법.
The method of claim 7, wherein
Primer capable of amplifying the promoter region described in SEQ ID NO: 18 is a molecular marker development method, characterized in that the primer pair described in SEQ ID NO: 29 and 30.
제 1항 내지 제 13항 중 어느 한 항의 방법으로 제작된 콩의 점무늬병 저항성 관련 유전자 특이적 분자마커.Claims 1 to 13 of the soybean disease produced by the method of any one of claims related gene-specific molecular markers.
KR1020100118096A 2010-11-25 2010-11-25 Method for Developing Gene Specific Molecular Markers for Soybean Frog-eye Disease Using Promoter Region Polymorphism KR101263785B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100118096A KR101263785B1 (en) 2010-11-25 2010-11-25 Method for Developing Gene Specific Molecular Markers for Soybean Frog-eye Disease Using Promoter Region Polymorphism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100118096A KR101263785B1 (en) 2010-11-25 2010-11-25 Method for Developing Gene Specific Molecular Markers for Soybean Frog-eye Disease Using Promoter Region Polymorphism

Publications (2)

Publication Number Publication Date
KR20120056520A true KR20120056520A (en) 2012-06-04
KR101263785B1 KR101263785B1 (en) 2013-05-15

Family

ID=46608645

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100118096A KR101263785B1 (en) 2010-11-25 2010-11-25 Method for Developing Gene Specific Molecular Markers for Soybean Frog-eye Disease Using Promoter Region Polymorphism

Country Status (1)

Country Link
KR (1) KR101263785B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101314168B1 (en) * 2010-11-30 2013-10-04 건국대학교 산학협력단 Method for developing gene specific molecular markers for discriminatinig soybean cultivars
CN106701960A (en) * 2017-01-15 2017-05-24 兰州大学 Medicago sativa.L ILP (Intron Length Polymorphism) molecular marker primer and application in Medicago sativa.L variety identification

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101314168B1 (en) * 2010-11-30 2013-10-04 건국대학교 산학협력단 Method for developing gene specific molecular markers for discriminatinig soybean cultivars
CN106701960A (en) * 2017-01-15 2017-05-24 兰州大学 Medicago sativa.L ILP (Intron Length Polymorphism) molecular marker primer and application in Medicago sativa.L variety identification
CN106701960B (en) * 2017-01-15 2020-05-22 兰州大学 Alfalfa ILP molecular marker primer and application thereof in alfalfa variety identification

Also Published As

Publication number Publication date
KR101263785B1 (en) 2013-05-15

Similar Documents

Publication Publication Date Title
CN107012246B (en) Soybean disease resistance quantitative trait locus and identification method of composition thereof
AU2015364304B2 (en) Fine mapping and validation of QTL underlying fiber content and seed coat color traits and identification of SNP markers for marker assisted selection of these traits derived from yellow seed coat (YSC) canola line YN01-429 and its lineage
CN104928286B (en) A kind of molecular labeling of the dominant grain length gene of rice
CN107338254B (en) Polynucleotides and methods for making plants resistant to fungal pathogens
CN111295447A (en) Maize elite event MZIR098
US20130266941A1 (en) Diagnostic assays for the detection and identification of aspergilli
KR100919753B1 (en) SCAR marker involving in powderly mildew resistance and selection method in melon thereof
KR101263785B1 (en) Method for Developing Gene Specific Molecular Markers for Soybean Frog-eye Disease Using Promoter Region Polymorphism
CN107338247B (en) SNP molecular marker associated with upland cotton fiber strength and application thereof
Imam et al. Identification of rice blast resistance gene Pi9 from Indian rice land races with STS marker and its verification by virulence analysis
Ma et al. Identification and fine mapping of gummy stem blight resistance gene Gsb-7 (t) in melon
KR101650987B1 (en) Universal primer set COS0566 for discrimination of Brassicaceae sp. and molecular marker comprising the same
Shang et al. Identification of a new rice blast resistance gene, Pid3, by genome-wide comparison of paired NBS-LRR genes and their pseudogene alleles between the two sequenced rice genomes
KR20120059212A (en) Method for developing gene specific molecular markers for discriminatinig soybean cultivars
WO2003068988A1 (en) A method of pcr based detection and identification of rice blast fungus magnaporthe grisea
KR101695051B1 (en) Universal primer set COS0842 for discrimination of Brassicaceae sp. and molecular marker comprising the same
KR101695053B1 (en) Universal primer set COS0264 for discrimination of Brassicaceae sp. and molecular marker comprising the same
KR101693068B1 (en) Universal primer set COS0424 for discrimination of Brassicaceae sp. and molecular marker comprising the same
KR101636111B1 (en) Universal primer set COS0084 for discrimination of Brassicaceae sp. and molecular marker comprising the same
CN108588259B (en) Insertion deletion fragment related to African rice shattering and application thereof
US20020142319A1 (en) Expressed sequences of Arabidopsis thaliana
SÜDÜPAK SURVEY OF GENE EXPRESSION DURING UREDOSPORE GERMINATION IN PUCCINIA SORGHI
KR101736670B1 (en) Primer sets for identification of Phalaenopsis and composition of marker comprising the same
CN114438100A (en) Method for efficiently separating bacterial leaf blight resistant gene with wild rice blood margin and family members thereof
KR101439455B1 (en) A High-density Genetic linkage map of Capsicum sp.

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20160602

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20170619

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee